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1.	  General	  experimental	  details	  
Chemicals	  and	  solvents	  were	  purchased	  from	  Aldrich	  Chemical	  Co.,	  Acros,	  TCI,	  and	  Fluorochem.	  Room	  
temperature	  (rt)	  refers	  to	  ambient	  temperature.	  Temperatures	  of	  0	  °C	  were	  maintained	  using	  an	  ice-­‐
water	  bath.	  Temperatures	  below	  0	  °C	  were	  maintained	  using	  an	  acetone-­‐cardice	  bath.	  Yields	  refer	  to	  
chromatographically	   and	   spectroscopically	   pure	   compounds.	   Analytical	   thin-­‐layer	   chromatograph	  
(TLC)	  was	  performed	  on	  precoated	  TLC	  plates	  (layer	  0.20	  mm	  silica	  gel	  60	  with	  fluorescent	  indicated	  
UV254,	   from	  Merck).	  Developed	  plates	  were	  air-­‐dried	  and	  analyzed	  under	  a	  UV	   lamp	  (UV	  254/365	  
nm)	   or	   sprayed	  with	   a	   potassium	   permanganate	   solution	   to	   visualize	   oxidizable	   substances.	   Flash	  
column	  chromatography	  was	  performed	  using	  prepacked	  silica	  gel	  catridge	  (230–400	  mesh,	  40–	  63	  
µm,	  from	  SiliCycle)	  using	  a	  Teledyne	  ISCO	  Combiflash	  Companion	  or	  Combiflash	  Retrieve.	  Microwave-­‐
assisted	  chemistry	  was	  conducted	  using	  either	  a	  CEM	  or	  Biotage	  initiator	  microwave	  synthesizer.	  1H	  
and	  13C	  NMR	  spectra	  were	  recorded	  either	  on	  a	  Bruker	  ARX-­‐400	  spectrometer	  (400	  and	  100	  MHz	  for	  
1H	   and	   13C	   NMR,	   respectively)	   or	   ARX-­‐500	   spectrometer	   (500	   and	   125	  MHz	   for	   1H	   and	   13C	   NMR,	  
respectively).	  Chemical	  shifts	  (δ)	  are	  reported	  in	  ppm	  relative	  to	  the	  residual	  solvent	  peak	  as	  internal	  
reference	  and	  coupling	  constants	  (J)	  are	  reported	  in	  hertz	  (Hz).	  Data	  are	  reported	  as	  follows:	  chemical	  
shift,	  multiplicity	   (br	  =	  broad,	   s	  =	  singlet,	  d	  =	  doublet,	   t	  =	   triplet,	  q	  =	  quartet,	  quint	  =	  quintet,	  m	  =	  
multiplet,	  *	  =	  refers	  to	  peaks	  of	  the	  minor	  isomer	  of	  a	  regioisomeric/rotational	  isomeric	  mixture,	  **	  =	  
refers	  to	  overlapping	  peaks	  of	  regioisomers/rotamers),	  integration.	  LC–MS	  analyses	  were	  performed	  
with	   either	   an	   Agilent	   HPLC	   1100	   series	   connected	   to	   a	   Bruker	   Daltonics	   MicrOTOF.	   LC–MS	  
chromatographic	  separations	  were	  conducted	  with	  a	  Waters	  XBridge	  C18	  column,	  50	  mm	  ×	  2.1	  mm,	  
3.5	   µm	   particle	   size;	   mobile	   phase,	   water–acetonitrile	   mixture	   with	   0.1%	   formic	   acid,	   or	   water–
acetonitrile	  mixture	  with	  0.1%	  ammonia;	   linear	  gradient	  from	  80:20	  to	  5:95	  over	  6.0	  minutes;	  flow	  
rate	   of	   0.5	   mL	   min–1.	   High	   resolution	   electrospray	   measurements	   were	   performed	   on	   a	   Bruker	  
Daltonics	   MicrOTOF	   mass	   spectrometer.	   HPLC	   purification	   was	   conducted	   using	   Waters	  
AutoPurification	  System	  with	  3100	  Mass	  Detector,	  with	  the	  column	  used	  either	  Waters	  XBridge	  C18	  
preparative	  OBD	  column,	  19	  mm	  ×	  100	  mm,	  5	  µm	  particle	  size,	  or	  Waters	  XSelect	  CSH	  C18	  preparative	  


















To	  a	  solution	  of	  3-­‐bromo-­‐1H-­‐pyrazole	  1	   (2.8g,	  19.7mmol)	   in	  H2SO4	  (9.0ml,	  177.5	  mmol)	  was	  added	  
HNO3	  (1.4ml,	  33.5mmol)	  at	  rt.	  Then,	  the	  temperature	  was	  raised	  up	  to	  50	  °C	  and	  the	  final	  solution	  
stirred	  overnight.	  Upon	   completion	  of	   the	   reaction,	   the	  mixture	  was	  poured	   into	  a	   cold	   saturated	  
solution	  of	  NaHCO3	  and	  extracted	  with	  EtOAc	  (3x).	  The	  combined	  organic	  fractions	  were	  washed	  with	  
brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo	  to	  afford	  2a	  as	  a	  white	  solid	  (3.6g,	  18.7mmol,	  95%).	  
¹H-­‐NMR	  (500	  MHz,	  DMSO-­‐d6):	  δ	  14.30	  (br,	  1H)	  ,	  8.91	  (s,	  1H);	  13C	  NMR	  (125	  MHz,	  DMSO-­‐d6):	  δ	  133.17,	  
133.09,	  121.85,	  107.44;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  191.9400	  ([M+H]+,	  79Br),	  193.9381	  ([M+H]+,	  81Br)	  




To	  a	  solution	  of	  2a	   (3.6g,	  18.7mmol)	   in	  MeCN	  (60ml)	  was	  added	  K2CO3	   (3.1g,	  22.44mmol)	  and	  the	  
mixture	  was	  stirred	  at	  rt	  for	  10	  min.	  Then,	  4-­‐methoxybenzyl	  chloride	  (5.0ml,	  37.4mmol)	  was	  added	  
and	  the	  temperature	  raised	  up	  to	  65	  °C.	  After	  48	  h,	  the	  reaction	  was	  quenched	  with	  saturated	  solution	  
of	   NH4Cl,	   the	   layers	   separated	   and	   the	   aqueous	   phase	   extracted	   with	   EtOAc	   (2x).	   The	   combined	  
organic	  fractions	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	   in	  vacuo.	  The	  residue	  
was	  purified	  by	  flash	  column	  chromatography	  (EtOAc/Heptane,	  15:85)	  to	  provide	  2	  as	  a	  white	  solid	  
(4.7g,	  15.06mmol,	  79%).	  
¹H	  NMR	  (500	  MHz,	  CDCl3):	  δ	  7.29-­‐7.27	  (2H,	  m),	  6.94-­‐6.92	  (2H,	  m),	  5.22	  (2H,	  s),	  3.83	  (3H,	  s);	  13C	  NMR	  
(125	  MHz,	  CDCl3)	  :	  δ	  160.51,	  133.58,	  130.58,	  130.42,	  124.74,	  122.22,	  114.80,	  57.47,	  55.41;	  LC-­‐MS,	  6	  
min	  run,	  (ESI+)	  m/z	  311.9985	  ([M+Na]+,	  79Br),	  313.9942	  ([M+Na]+,	  81Br)	  Rt	  =	  2.3	  min.	  
	  




To	  a	  solution	  1	  (2.9g,	  19.8mmol)	  in	  MeCN	  (60ml)	  was	  added	  K2CO3	  (3.3g,	  23.76mmol)	  and	  the	  mixture	  
was	  stirred	  at	  rt	  for	  10	  min.	  Then,	  4-­‐methoxybenzyl	  chloride	  (4.0ml,	  39.6mmol)	  was	  added	  and	  the	  
temperature	   raised	  up	   to	  65	   °C.	  After	  48	  h,	   the	   reaction	  was	  quenched	  with	  saturated	  solution	  of	  
NH4Cl,	  the	  layers	  separated	  and	  the	  aqueous	  phase	  extracted	  with	  EtOAc	  (2x).	  The	  combined	  organic	  
fractions	   were	   washed	   with	   brine,	   dried	   over	   MgSO4	   and	   evaporated	   in	   vacuo.	   The	   residue	   was	  
purified	  by	  flash	  column	  chromatography	  (EtOAc/Heptane,	  20:80)	  to	  provide	  a	  1:0.25	  regioisomeric	  
mixture	   ((3-­‐bromo-­‐1-­‐(4-­‐methoxybenzyl)-­‐1H-­‐pyrazole:	   5-­‐bromo-­‐1-­‐(4-­‐methoxybenzyl)-­‐1H-­‐pyrazole)	  
1:0.25	  (3a’:3a’’))	  	  as	  a	  white	  solid	  (5.0g,	  18.7mmol,	  95%).	  	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  	  δ	  7.54	  (s,	  0.25H)*,	  7.24-­‐7.20	  (m,	  3.5H)**,	  6.91	  (m,	  2H),	  6.88	  (m,	  0.5H)*,	  6.33	  
(s,	  0.25H)*,	  6.28	  (s,	  1H),	  5.33	  (s,	  0.5H)*,	  5.22	  (s,	  2H),	  3.82	  (s,	  3H),	  3.80	  (s,	  0.75H)*;	  13C	  NMR	  (125	  MHz,	  
CDCl3):	   δ	   159.68,	   159.31,	   140.46,	   130.90,	   129.56,	   128.95,	   128.26,	   127.54,	   125.44,	   114.29,	   114.09,	  
112.61,	  108.83,	  108.75,	  56.09,	  55.32,	  55.27,	  53.38;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  288.9955	  ([M+Na]+,	  




To	  a	  solution	  of	  3a’+3a’’	  (5.0g,	  18.7mmol)	  in	  DMF	  (14.0	  ml)	  was	  added	  POCl3	  (15	  ml)	  at	  rt.	  Then,	  the	  
temperature	  was	   raised	   up	   to	   95	   °C	   and	   the	   final	  mixture	  was	   stirred	   for	   4	   h.	   Subsequently,	   the	  
solution	   was	   dropwise	   added	   to	   a	   cooled	   saturated	   solution	   of	   NaHCO3	   and,	   after	   the	   quenched	  
mixture	   reached	   rt,	   extracted	  with	   EtOAc	   (2x).	   The	   combined	  organic	   fractions	  were	  washed	  with	  
brine,	   dried	   over	   MgSO4	   and	   evaporated	   in	   vacuo.	   The	   residue	   was	   purified	   by	   flash	   column	  
chromatography	  (EtOAc/Heptane,	  20:80)	  to	  3	  as	  a	  yellow	  solid	  (3.6g,	  12.1mmol,	  65%).	  	  
¹H	  NMR	  (400	  MHz,	  CDCl3):	  δ	  9.73	  (1H,	  s),	  7.72	  (1H,	  s),	  7.26	  -­‐	  7.22	  (2H,	  m),	  6.94	  -­‐	  6.89	  (2H,	  m),	  5.21	  (2H,	  
s),	   3.82	   (3H,	   s);	   13C	   NMR	   (100MHz,	   DMSO-­‐d6):	   δ	   184.17,	   160.53,	   132.94,	   130.17,	   129.16,	   125.55,	  
121.99,	  114.72,	  56.90,	  55.32;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  295.0080	  ([M+H]+,	  79Br),	  297.0089	  ([M+H]+,	  




To	  a	  suspension	  of	  2	  1.42g,	  4.53mmol)	  in	  EtOH	  (15mL),	  iron	  (2.03g,	  36.24mmol)	  	  	  and	  NHCl4	  (970mg,	  
18.12mmol)	  in	  water	  (4.5	  ml)	  were	  added.	  The	  reaction	  mixture	  was	  heated	  at	  80°	  C	  for	  2	  h.	  Upon	  
completion,	  the	  reaction	  mixture	  was	  allowed	  to	  reach	  r.t.,	  it	  was	  basified	  with	  Na2CO3	  and	  was	  filtered	  
through	   a	   pad	   of	   celite	   eluting	   with	   DCM.	   Afterwards,	   volatiles	   were	   removed	   under	   vacuum,	  
S5	  
	  
water	  was	  added	  and	  extracted	  with	  DCM	  (2x).	  The	  combine	  organics	  were	  then	  washed	  with	  brine,	  
dried	  over	  MgSO4	  and	  evaporated	  under	  vacuum	  to	  afford	  20	  (1.2g,	  4.26mmol,	  94%)	  as	  a	  red	  oil.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.18	  -­‐	  7.16	  (m,	  2H),	  6.87	  -­‐	  6.85	  (m,	  3H),	  5.08	  (s,	  2H),	  3.79	  (s,	  3H),	  2.93	  (s,	  
2H);	   13C	  NMR	   (125	  MHz,	   CDCl3):	   δ	   159.59,	   129.41,	   128.07,	   127.97,	   118.65,	   117.92,	   114.21,	   56,38,	  




To	  a	  solution	  of	  20	  (368mg,	  1.30mmol)	  and	  	  pyridine	  (0.12ml,	  1.43mmol)	  in	  DCM	  (4mL)	  at	  0	  oC	  ,	  acetyl	  
chloride	  (1.0ml,	  1.30mmol)	  was	  added	  and	  the	  reaction	  was	  left	  under	  stirring	  at	  0	  oC	  for	  1	  h.	  Then,	  a	  
saturated	  solution	  of	  NH4Cl	  was	  added	  and	  the	  two	  layers	  were	  separated.	  The	  aq.	  layer	  was	  further	  
extracted	  with	  DCM	  (2x).	   	   	  The	  combined	  organics	  were	  washed	  with	  brine	  and	  dried	  over	  MgSO4	  
before	   concentration	   to	   dryness.	   The	   crude	   was	   then	   purified	   by	   flash	   column	   chromatography	  
(EtOAc/Heptane,	  45:55).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  21b	  
(392mg,	  1.20mmol,	  92%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.92	  (s,	  1H),	  7.21	  -­‐	  7.18	  (m,	  2H),	  6.96	  (s,	  1H),	  6.86	  -­‐	  6.84	  (m,	  2H),	  5.13	  (s,	  
2H),	  3.78	  (s,	  3H),	  2.15	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  166.83,	  159.70,	  129.55,	  127.51,	  122.60,	  
120.14,	  115.87,	  114.30,	  56.67,	  55.31,	  23.48;	  LC-­‐MS,	  6	  min	  run,	   (ESI+)	  m/z	  324.0375	   ([M+H]+,	   79Br),	  




To	   a	   mixture	   20	   (330mg,	   1.17mmol)	   	   and	   	   pyridine	   (0.10ml,	   1.28mmol)	   in	   DCM	   (3.8mL),	  
methanesulfonyl	  chloride	  (0.09ml,	  1.28mmol)	  was	  added	  at	  0	  °C.	  The	  mixture	  was	  stirred	  at	  0	  °C	  for	  2	  
h.	  Then,	  a	  saturated	  solution	  of	  NH4Cl	  was	  added	  and	  the	  two	  layers	  were	  separated.	  The	  aq.	  layer	  
was	  further	  extracted	  with	  DCM	  (2x).	  The	  combined	  organics	  were	  washed	  with	  brine	  and	  dried	  over	  
MgSO4	  before	  concentration	  to	  dryness	  to	  afford	  21c	   (410mg,	  1.13mmol,	  96%)	  as	  a	  pink	  solid.	  The	  
solid	  was	  pure	  enough	  to	  be	  used	  in	  the	  next	  step	  without	  further	  purification.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  7.43	  (s,	  1H),	  7.24-­‐7.20	  (m,	  2H),	  6.91-­‐6.87	  (m,	  2H),	  5.82	  (s,	  1H),	  5.15	  (s,	  
2H),	  3.81	  (s,	  3H),	  2.96	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  159.96,	  129.86,	  127.90,	  126.53,	  122.52,	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117.73,	  114.47,	  57.07,	  55.34,	  39.65;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  360.0010	  ([M+H]+,	  79Br),	  362.0011	  
([M+H]+,	  81Br)	  Rt	  =	  2.8	  min.	  
	  
tert-­‐butyl	  allyl(3-­‐bromo-­‐1-­‐(4-­‐methoxybenzyl)-­‐1H-­‐pyrazol-­‐4-­‐yl)carbamate	  (22a)	  
	  
To	  a	  solution	  of	  20	  (275mg,	  0.97mmol)	  and	  Et3N	  (0.16ml,	  1.16mmol)	  in	  THF	  (2	  mL)	  at	  rt	  under	  nitrogen	  
was	  added	  Boc	  anhydride	  (255mg,	  1.16mmol)	  solution	  in	  THF	  (1ml).	  The	  reaction	  mixture	  was	  stirred	  
at	  rt	  for	  24	  h.	  The	  solvent	  was	  removed	  under	  reduced	  pressure.	  The	  crude	  product	  (21a)	  was	  used	  in	  
the	  next	  step	  without	  further	  purification.	  The	  crude	  (21a)	  was	  dissolved	  in	  THF	  (8ml)	  under	  nitrogen	  
at	  0	  °C	  and	  NaH	  (60%	  dispersion	  in	  mineral	  oil,	  58mg,	  1.45mmol)	  was	  added	  portionwise.	  The	  reaction	  
mixture	  was	  allowed	  to	  warm	  up	  to	  rt,	  then	  3-­‐bromoprop-­‐1-­‐ene	  (0.1ml,	  1.16mmol)	  	  	  was	  added.	  The	  
reaction	  mixture	  was	  stirred	  under	  reflux	  overnight.	  The	  reaction	  was	  cooled	  and	  EtOAc	  was	  added,	  
then	  water	  was	  carefully	  added.	  The	  aq.	  layer	  was	  extracted	  with	  EtOAc	  (3x).	  The	  combined	  organics	  
were	  then	  washed	  and	  dried	  over	  MgSO4	  before	  concentration	  to	  dryness.	  The	  crude	  was	  then	  purified	  
by	  flash	  column	  chromatography	  (EtOAc/	  Heptane,	  25:75).	  The	  desired	  fractions	  were	  concentrated	  
to	  dryness	   in	   vacuo	   to	   afford	  22a	   (340mg,	   0.80	  mmol,	   82%)	   as	   a	  white	   solid.	   Compound	  22a	  was	  
isolated	  as	  a	  mixture	  1:0.2	  of	  two	  rotamers.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.43	  (s,	  0.2H)*,	  7.16	  (br,	  3.4H)**,	  6.85-­‐6.82	  (m,	  2H),	  6.81-­‐6.78	  (m,	  0.4H)*,	  
5.86	  -­‐	  5.74	  (m,	  1.2H)**,	  5.26	  (s,	  0.4H)*,	  5.12	  (s,	  2H),	  5.08	  (m,	  0.4H)*,	  5.06	  (t,	  J=1.4	  Hz,	  1H),	  5.03	  (qd,	  
J=1.4,	  7.5	  Hz,	  1H),	  4.06	  (br,	  2.4H)**,	  3.76	  (s,	  3H),	  3.74	  (s,	  0.6H)*,	  1.41	  (s,	  10.8H)**;	  13C	  NMR	  (125	  MHz,	  
CDCl3):	   δ	   159.66,	   159.28,	   154.35,	   137.77,	   133.74,	   129.14,	   128.37,	   127.99,	   127.51,	   125.17,	   124.16,	  
117.42,	  114.26,	  114.05,	  80.57,	  56.55,	  55.29,	  55.24,	  54.15,	  52.32,	  28.16;	  broadening	  of	  peaks	  is	  due	  to	  
the	   slow	   rotation	  of	   the	  carbamate	   linkage;	  LC-­‐MS,	   6	  min	   run,	   (ESI+)	  m/z	  422.1087	   ([M+H]+,	   79Br),	  




To	  a	  mixture	  of	  21b	  (392mg,	  1.20mmol)	  	  and	  3-­‐bromoprop-­‐1-­‐ene	  (0.21ml,	  2.40mmol)	  	  in	  DMF	  (5mL)	  	  ,	  
NaH	  (60%	  dispersion	  in	  mineral	  oil,	  100mg,	  2.40mmol)	  	  was	  added	  portionwise	  at	  0	  °C.	  The	  reaction	  
was	  then	  left	  at	  rt	  for	  2	  h.	  Once	  the	  starting	  material	  was	  completely	  consumed,	  a	  saturated	  solution	  
of	  NH4Cl	  was	  added	  and	  extraction	  was	  performed	  with	  DCM	  (3x).	  The	  organics	  were	  then	  separated,	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washed	  with	  brine	  and	  dried	  over	  MgSO4	  before	  concentration	  to	  dryness.	  The	  crude	  was	  then	  purified	  
by	  flash	  column	  chromatography	  (EtOAc/	  Heptane,	  35:65).	  The	  desired	  fractions	  were	  concentrated	  
to	  dryness	  in	  vacuo	  to	  provide	  22b	  (386mg,	  1.05mmol,	  87%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  d	  7.22	  -­‐	  7.19	  (m,	  3H),	  6.93	  -­‐	  6.91	  (m,	  2H),	  5.83	  -­‐	  5.74	  (m,	  1H),	  5.20	  (s,	  2H),	  
5.11	  (qd,	  J=1.2,	  10.2	  Hz,	  1H),	  5.05	  (qd,	  J=1.2,	  17.0	  Hz,	  1H),	  4.19	  (br,	  2H),	  3.84	  (s,	  3H),	  1.91	  (s,	  3H);	  13C	  
NMR	   (125	  MHz,	   CDCl3):	   δ	   171.07,	   15.92,	   132.99,	   129.55,	   128.41,	   126.76,	   125.60,	   124.79,	   118.25,	  
114.46,	  56.90,	  55.34,	  51.32,	  22.21;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  364.0675	  ([M+H]+,	  79Br),	  366.0659	  




To	   a	   mixture	   of	   21c	   (410mg,	   1.13	   mmol)	   and	   K2CO3	   (236mg,	   1.69mmol)	   in	   MeCN	   (7.5mL),	   3-­‐
bromoprop-­‐1-­‐ene	  (0.15ml,	  1.69mmol)	  was	  added.	  The	  final	  mixture	  was	  heated	  under	  reflux	  for	  2h.	  
Then,	  a	  saturated	  solution	  of	  NH4Cl	  was	  added	  and	  extraction	  was	  carried	  out	  with	  EtOAc	  (3x).	  The	  
combined	  organics	  were	  washed	  with	  brine	  and	  dried	  over	  MgSO4	  before	  concentration	  to	  dryness.	  
The	  crude	  was	  then	  purified	  by	  flash	  column	  chromatography	  (EtOAc/	  Heptane,	  30:70).	  The	  desired	  
fractions	  were	  concentrated	  to	  dryness	   in	  vacuo	  to	  afford	  22c	   (406mg,	  1.01mmol,	  89%)	  as	  a	  white	  
solid.	  
¹H	  NMR	  (500	  MHz,	  CDCl3):	  δ	  7.33	  (s,	  1H),	  7.21	  -­‐	  7.17	  (m,	  2H),	  6.90	  -­‐	  6.87	  (m,	  2H),	  5.83	  -­‐	  5.74	  (m,	  1H),	  
5.14-­‐5.10	  (m,	  3H),	  4.15	  (dt,	  J=1.2,	  6.4	  Hz,	  2H),	  3.80	  (s,	  3H),	  2.98	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  
159.90,	  132.85,	  131.93,	  129.77,	  126.49,	  124.70,	  119.83,	  119.28,	  114.44,	  56.97,	  55.34,	  53.2,	  39.97;	  LC-­‐




A	  microwave	  vial	  was	  charged	  with	  22a	  (340mg,	  0.80mmol)	  Pd(dppf)Cl2	  (58.7mg,	  0.08mmol)	  	  Cs2CO3	  
(525mg,	  1.60mmol)	  and	  DMF	  (3.5	  mL).	  The	  vial	  was	  evacuated	  and	  backfilled	  three	  times	  with	  nitrogen	  
and	  heated	  under	  microwave	  irradiation	  conditions	  at	  140	  °C	  and	  200	  W	  for	  30min.	  Then,	  was	  were	  
added	  and	  extraction	  was	  carried	  out	  with	  EtOAc	  (3x).	  The	  combined	  organics	  were	  washed	  with	  brine	  
and	  dried	  over	  MgSO4	  before	  concentration	  to	  dryness.	  The	  crude	  was	  then	  purified	  by	  flash	  column	  
chromatography	   (EtOAc/	   Heptane,	   35:65).	   The	   desired	   fractions	   were	   concentrated	   to	   dryness	   in	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vacuo	  to	  afford	  23a	  (Boc	  protected)	  (170mg,	  0.50mmol,	  62%)	  as	  a	  white	  solid.	  A	  small	  amount	  of	  the	  
latter	  was	  deprotected	  by	  using	  TFA	  in	  DCM,	  in	  order	  to	  get	  more	  comprehensible	  NMR	  spectra.	  LC-­‐
MS	  values	  of	  both	  the	  protected	  and	  deprotected	  version	  are	  reported.	  
¹H	  NMR	  (without	  Boc)	  (500	  MHz,	  MeOD4)	  δ	  7.31	  -­‐	  7.30	  (m,	  1H),	  7.15	  (m,	  2H),	  6.86	  -­‐	  6.83	  (m,	  3H),	  5.29	  
(s,	  2H),	  3.74	  (s,	  3H),	  2.18	  (t,	  3H,	  J=	  1.1	  Hz);	  13C	  NMR	  (without	  Boc)	  (125	  MHz,	  CDCl3):	  δ	  159.35,	  149.87,	  
129.68,	  128.52,	  128.38,	  127.21,	  113.53,	  109.05,	  101.27,	  55.29,	  54.2,	  8.24;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  
m/z	  342.1222	  [M+H]+	  (with	  Boc)	  Rt	  =	  3.8	  min;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  242.1298	  [M+H]+	  	  (without	  




A	  microwave	  vial	  was	  charged	  with	  22b	  (385mg,	  1.05mmol),	  Pd(dppf)Cl2	  (78mg,	  0.105mmol),	  Cs2CO3	  
(685mg,	  2.10mmol)	  and	  DMF	  (4.0	  mL).	  The	  vial	  was	  evacuated	  and	  backfilled	  three	  times	  with	  nitrogen	  
and	  heated	  under	  microwave	  irradiation	  conditions	  at	  140	  °C	  and	  200	  W	  for	  30min.	  Then,	  water	  was	  
added	  and	  extraction	  was	  carried	  out	  with	  EtOAc	  (3x).	  The	  combined	  organics	  were	  washed	  with	  brine	  
and	  dried	  over	  MgSO4	  before	  concentration	  to	  dryness.	  The	  crude	  was	  then	  purified	  by	  flash	  column	  
chromatography	   (EtOAc/	   Heptane,	   50:50).	   The	   desired	   fractions	   were	   concentrated	   to	   dryness	   in	  
vacuo	   to	   afford	   23b	   (207mg,	   0.73mmol,	   69%)	   as	   a	   white	   solid.	   Compound	   23b	   was	   isolated	   as	   a	  
mixture	  1:0.5	  of	  two	  rotamers.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.58	  (s,	  1H),	  7.43	  (br,	  0.5H)*,	  7.24-­‐7.19	  (m,	  3H)*,	  7.13	  (s,	  0.5H)*,	  6.94	  (q,	  
J=1.2	  Hz,	  1H)	  6.90	  -­‐	  6.83	  (m,	  3H),	  5.35	  (s,	  1H)*,	  5.34	  (s,	  2H),	  3.80	  (s,	  1.5H)*,	  3.79	  (s,	  3H),	  2.43	  (s,	  3H),	  
2.42	  (s,	  1.5H)*,	  2.25	  (d,	  J=1.2	  Hz,	  3H),	  2.24	  (br,	  1.5H)*;	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  165.80,	  165.39,	  
159.50,	  150.0,	  129.31,	  129.21,	  128.60,	  128.50,	  125.66,	  125.52,	  124.31,	  114.94,	  114.3	  114.2,	  113.9,	  
112.31,	  56.62,	  56.56,	  55.31,	  23.24,	  21.26,	  9.90,	  9.75;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  284.1419	  [M+H]+,	  




A	  microwave	  vial	  was	  charged	  with	  22c	  (406mg,	  1.01mmol),	  Pd(dppf)Cl2	  (74mg,	  0.101mmol)	  Cs2CO3	  
(660mg,	  2.02mmol)	  and	  DMF	  (3.5mL)	  .	  The	  vial	  was	  evacuated	  and	  backfilled	  three	  times	  with	  nitrogen	  
and	  heated	  under	  microwave	  irradiation	  conditions	  at	  140	  °C	  and	  200	  W	  for	  30min.	  Then,	  water	  was	  
added	  and	  extraction	  was	  carried	  out	  with	  EtOAc	  (3x).	  The	  combined	  organics	  were	  washed	  with	  brine	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and	  dried	  over	  MgSO4	  before	  concentration	  to	  dryness.	  The	  crude	  was	  then	  purified	  by	  flash	  column	  
chromatography	   (EtOAc/	   Heptane,	   40:60).	   The	   desired	   fractions	   were	   concentrated	   to	   dryness	   in	  
vacuo	  to	  afford	  23c	  (256mg,	  0.80mmol,	  79%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.37	  (s,	  1H),	  7.24-­‐7.21	  (m,	  2H),	  6.91	  (q,	  J=1.4	  Hz,	  1H),	  6.88-­‐6.85	  (m,	  2H),	  
5.33	   (s,	  2H),	  3.79	   (s,	  4H),	  2.87	  (s,	  3H),	  2.25	  (d,	   J=1.4	  Hz,	  3H);	  13C	  NMR	   (125	  MHz,	  CDCl3):	  δ	  159.68,	  
150.49,	  129,51,	  128.13,	  127.12,	  125.34,	  115.28,	  114.34,	  113.09,	  56.86,	  55.30,	  38.75,	  9.76;	  LC-­‐MS,	  6	  




A	  0.05	  M	  solution	  of	  23a	  (170mg,	  0.50mmol)	  in	  EtOH	  (10ml)	  was	  hydrogenated	  in	  H-­‐cube	  Pro.	  Initially,	  
the	  parameters	  (temperature:	  50°C,	  pressure:	  50bar,	  and	  flowrate:	  0.5ml/min)	  were	  selected	  on	  H-­‐
cube	  and	  a	  10%	  Pd/C	  CatCart	  was	  fitted	  in	  the	  instrument.	  After	  pumping	  pure	  EtOH	  for	  10	  min,	  the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (4.5ml)	   and	   anisole	   (0.33ml,	   3.0mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for12	  h.	  After	  cooling,	  
volatiles	  were	  evaporated	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  
sample	  was	   filtered	   and	   injected	   in	   an	  AutoPurification	  HPLC/MS	   system	  and	  purified	  under	  basic	  
conditions.	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  to	  provide	  4a	  (30mg,	  0.26mmol,	  52%)	  
as	  a	  colourless	  oil.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.21	  (s,	  1H),	  4.12	  (dd,	  J=8.3,	  10.5	  Hz,	  1H),	  3.51	  (dd,	  J=6.9,	  10.5	  Hz,	  1H),	  
3.40	  (qdd,	  J=	  6.7,	  6.9,	  8.3	  Hz,	  1H),	  1.33	  (d,	  J=6.7	  Hz,	  3H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ156.63,	  131.97,	  




A	  0.05	  M	  solution	  of	  23b	  (207mg,	  0.73mmol)	  in	  EtOH	  (15ml)	  was	  hydrogenated	  in	  H-­‐cube.	  Initially,	  the	  
parameters	  (temperature:	  50°C,	  pressure:	  50bar,	  and	  flowrate:	  0.5ml/min)	  were	  selected	  on	  H-­‐cube	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   and	   anisole	   was	   subsequently	   added	   to	   the	  
reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  volatiles	  were	  evaporated	  
and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  sample	  was	  filtered	  and	  
injected	   in	   an	   AutoPurification	   HPLC/MS	   system	   and	   purified	   under	   basic	   conditions.	   The	   desired	  
fractions	   were	   concentrated	   to	   dryness	   to	   provide	   4b	   (73mg,	   0.44mmol,	   60%)	   as	   a	   white	   solid.	  




¹H-­‐NMR	   (500	  MHz,	  MeOD):	   	  δ	  7.40	  (s,	  1H),	  7.30	  (s,	  0.77H)*,	  4.63	  (dd,	  J=9.2,	  10.7	  Hz,	  1H),	  4.52	  (dd,	  
J=9.1,	  12.1	  Hz,	  0.77H)*,	  3.98	  (dd,	  J=5.8,	  10.7	  Hz,	  1H),	  3.83	  (dd,	  J=5.8,	  12.1	  Hz,	  0.77H)*,	  3.60	  (qdd,	  J=5.8,	  
7.0,	  9.2	  Hz,	  1H),	  3.47	  (qdd,	  J=5.8,6.8,	  9.1	  Hz,	  0.77H)*,	  2.21	  (s,	  2.3H)*,	  2.13	  (s,	  3H),	  1.36	  (d,	  J=7.0	  Hz,	  3H),	  
1.33	   (d,	   J=6.8	  Hz,	  2.3H)*;	   13C	  NMR	   (125	  MHz,	   ,	  MeOD4):	  δ	  169.76,	  168.76,	  155.44,	  154.61,	  129.55,	  
129.34,	  116.45,	  115.26,	  63.82,	  62.53,	  32.87,	  31.31,	  22.86,	  21.39,	  19.62,	  19.60;	  HRMS	   (ESI):	   [M+H]+	  




A	  0.05	  M	  solution	  of	  23c	  (256mg,	  0.80mmol)	  in	  EtOH	  (16	  ml)	  was	  hydrogenated	  in	  H-­‐cube.	  Initially,	  
the	  parameters	  (temperature:	  50°C,	  pressure:	  50bar,	  and	  flowrate:	  0.5ml/min)	  were	  selected	  on	  H-­‐
cube	  and	  a	  10%	  Pd/C	  CatCart	  was	  fitted	  in	  the	  instrument.	  After	  pumping	  pure	  EtOH	  for	  10	  min,	  the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   and	   anisole	   was	   subsequently	   added	   to	   the	  
reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  volatiles	  were	  evaporated	  
and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  sample	  was	  filtered	  and	  
injected	   in	   an	   AutoPurification	   HPLC/MS	   system	   and	   purified	   under	   basic	   conditions.	   The	   desired	  
fractions	  were	  concentrated	  to	  dryness	  to	  provide	  4c	  (90mg,	  0.45mmol,	  56%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.21	  (s,	  1H),	  4.44	  (dd,	  J=8.7,	  11.1	  Hz,	  1H),	  3.80	  (dd,	  J=6.6,	  11.1	  Hz,	  1H),	  
3.55	  (qdd,	  J=6.6,	  6.9,	  8.7	  Hz,	  1H),	  2.87	  (s,	  3H),	  1.35	  (d,	  J=6.9	  Hz,	  3H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  
154.79,	   130.27,	   116.22,	   65.85,	   33.25,	   32.85,	   19.05;	   HRMS	   (ESI):	   [M+H]+	   calcd.	   for	   C7H11N3O2S:	  




A	   flask	   was	   charged	   with	   2	   (1.22g,	   3.90mmol),	   CsF	   (1250mg,	   7.80mmol),	   	   	   Pd(t-­‐Bu3P)2	   (104mg,	  
0.19mmol)	   	  and	  THF	  (22	  mL)	  under	  nitrogen	  atmosphere.	  Then,	  tributyl(vinyl)stannane	  (257.87mg,	  
4.68mmol)	  	  was	  added	  and	  the	  final	  mixture	  was	  stirred	  at	  rt	  for	  24	  h.	  Subsequently,	  the	  reaction	  was	  
diluted	  with	  Et2O	  and	  water	  was	  added.	  The	  two	  layers	  were	  separated	  and	  the	  aq.	  one	  was	  extracted	  
further	  with	  Et2O	  (2x).	  The	  combined	  organics	  were	  washed	  with	  brine	  and	  dried	  over	  MgSO4	  before	  
concentration	  to	  dryness.	  The	  crude	  was	  then	  passed	  through	  celite	  eluting	  with	  DCM	  and	  purified	  by	  
flash	  column	  chromatography	  (EtOAc/	  Heptane,	  20:80).	  The	  desired	  fractions	  were	  concentrated	  to	  
dryness	  in	  vacuo	  to	  afford	  24	  (933mg,	  3.32mmol,	  85%)	  as	  a	  colourless	  oil.	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¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.94	  (s,	  1H),	  7.28-­‐7.25	  (m,	  2H),	  7.21	  (dd,	  J=11.2,	  17.7	  Hz,	  1H),	  6.94	  -­‐	  6.92	  
(m,	  2H),	  6.22	  (dd,	  J=1.8,	  17.7	  Hz,	  1H),	  5.54	  (dd,	  J=1.8,	  11.2	  Hz,	  1H),	  5.21	  (s,	  2H),	  3.83	  (s,	  3H);	  13C	  NMR	  
(125	  MHz,	  CDCl3):	  δ	  160.27,	  144.97,	  130.21,	  129.62,	  125.48,	  120.01,	  120.56,	  114.69,	  56.93,	  55.39;	  LC-­‐




To	  a	  suspension	  of	  24	  (933mg,	  3.32mmol)	  in	  EtOH	  (10mL),	  iron	  (1.60g,	  26.5mmol)	  and	  NH4Cl	  (770mg,	  
13.28mmol)	  in	  water	  (1.7	  ml)	  were	  added.	  The	  reaction	  mixture	  was	  heated	  at	  80	  °C	  for	  2	  h.	  Upon	  
completion,	  the	  reaction	  mixture	  was	  allowed	  to	  reach	  rt,	  it	  was	  basified	  with	  Na2CO3	  and	  was	  filtered	  
through	   a	   pad	   of	   celite	   eluting	   with	   DCM.	   Afterwards,	   volatiles	   were	   removed	   under	   vacuum,	  
water	  was	  added	  and	  extracted	  with	  DCM	  (2x).	  The	  combined	  organics	  were	  then	  washed	  with	  brine,	  
dried	   over	   MgSO4	   and	   evaporated	   under	   vacuum.	   The	   crude	   was	   then	   purified	   by	   flash	   column	  
chromatography	  (MeOH/	  DCM,	  8:92).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  
afford	  25	  (650mg,	  2.79mmol,	  84%)	  as	  a	  reddish	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.18-­‐7.15	  (m,	  2H),	  6.87-­‐6.84	  (d,	  2H),	  6.86	  (s,	  1H),	  6.71	  (dd,	  J=11.7,	  18.2	  
Hz,	  1H),	  5.69	  (dd,	  J=1.4,	  18.2	  Hz,	  1H),	  5.29	  (dd,	  J=1.4,	  11.7	  Hz,	  1H),	  5.09	  (s,	  2H),	  3.79	  (s,	  3H),	  2.54	  (br,	  
2H);	   13C	  NMR	   (125	  MHz,	  CDCl3):	  δ	  159.42,	  139.75,	  129.20,	  128.60,	  128.02,	  127.71,	  118.73.	  114.14,	  




To	  a	  solution	  of	  25	  (155mg,	  0.68mmol)	  and	  pyridine	  (0.083ml,	  1.02mmol)	  in	  DCM	  2mL)	  at	  0	  oC	  ,	  acetyl	  
chloride	  (0.081ml,	  0.68mmol)	  was	  added	  and	  the	  reaction	  was	  left	  under	  stirring	  at	  0	  oC	  for	  1	  h.	  Then,	  
a	  saturated	  solution	  of	  NH4Cl	  was	  added	  and	  the	  two	  layers	  were	  separated.	  The	  aq.	  layer	  was	  further	  
extracted	  with	   DCM	   (2x).	   The	   combined	   organics	  were	  washed	  with	   brine	   and	   dried	   over	  MgSO4	  
before	   concentration	   to	   dryness.	   The	   crude	   was	   then	   purified	   by	   flash	   column	   chromatography	  
(MeOH/	   DCM,	   3:97).	   The	   desired	   fractions	   were	   concentrated	   to	   dryness	   in	   vacuo	   to	   afford	   26b	  
(160mg,	  0.58	  mmol,	  85%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  7.88	  (s,	  1H),	  7.20-­‐7.17	  (m,	  2H),	  7.10	  (br,	  1H),	  6.86-­‐6.83	  (d,	  2H),	  6.64	  (dd,	  
J=11.4,	  18.0	  Hz,	  1H),	  5.71	  (dd,	  J=1.0,	  18.0	  Hz,	  1H),	  5.35	  (dd,	  J=1.0,	  11.4	  Hz,	  1H),	  5.14	  (s,	  2H),	  3.78	  (s,	  
3H),	  2.12	  (s,	  3H);	  13C	  NMR	  (100	  MHz,	  CDCl3):	  δ	  167.31,	  159.51,	  139.37,	  129.38,	  128.07,	  126.87,	  123.19,	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To	   a	   mixture	   of	   25	   (130mg,	   0.57mmol)	   and	   pyridine	   (0.069ml,	   0.85mmol)	   in	   DCM	   (2mL),	  
methanesulfonyl	  chloride	  (0.044ml,	  0.57mmol)	  was	  added	  at	  0	  °C.	  The	  mixture	  was	  stirred	  at	  0	  °C	  for	  2	  
h.	  Then,	  a	  saturated	  solution	  of	  NH4Cl	  was	  added	  and	  the	  two	  layers	  were	  separated.	  The	  aq.	  layer	  
was	  further	  extracted	  with	  DCM	  (2x).	  The	  combined	  organics	  were	  washed	  with	  brine	  and	  dried	  over	  
MgSO4	  before	  concentration	  to	  dryness	  to	  afford	  26c	  (162mg,	  0.52mmol,	  91%)	  as	  a	  reddish	  solid.	  The	  
latter	  was	  pure	  enough	  to	  be	  used	  in	  the	  next	  step	  without	  further	  purification.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  	  δ	  7.40	  (s,	  1H),	  7.21	  -­‐	  7.18	  (m,	  2H),	  6.88	  -­‐	  6.85	  (m,	  2H),	  6.63	  (dd,	  J=11.4,	  17.9	  
Hz,	  1H),	  6.35	  (s,	  1H),	  5.94	  (dd,	  J=1.4,	  17.9	  Hz,	  1H),	  5.35	  (dd,	  J=1.4,	  11.4	  Hz,	  1H),	  5.14	  (s,	  2H),	  3.79	  (s,	  
3H),	  2.89	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  159.70,	  144.65,	  129.58,	  128.04,	  127.42,	  125.82,	  116.81,	  
115.46,	  114.34,	  56.31,	  55.33,	  39.17;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  308.1093	  [M+H]+,	  Rt	  =	  2.7	  min	  
	  
tert-­‐butyl	  allyl(1-­‐(4-­‐methoxybenzyl)-­‐3-­‐vinyl-­‐1H-­‐pyrazol-­‐4-­‐yl)carbamate	  (27a)	  
	  
To	  a	  solution	  of	  	  	  25	  (200mg,	  0.87mmol)	  and	  Et3N	  (0.15ml,	  1.05ml)	  in	  THF	  (3mL)	  at	  rt	  under	  nitrogen	  
was	   added	   	   Boc	   anhydride	   (210mg,	   0.95mmol)	   solution	   in	   THF	   (0.8ml).	   The	   reaction	  mixture	  was	  
stirred	  at	  25	  °C	  for	  12h.	  Then,	  volatiles	  were	  removed	  under	  reduced	  pressure	  and	  the	  crude	  product	  
(26a)	  was	  used	  in	  the	  next	  step	  without	  further	  purification.	  The	  latter	  was	  dissolved	  in	  THF	  (4.7ml)	  
under	   nitrogen	   at	   0	   °C	   and	   NaH	   (60%	   dispersion	   in	   mineral	   oil,	   53mg,	   1.3mmol)	   was	   added	  
portionwise.	  The	  reaction	  mixture	  was	  allowed	  to	  warm	  up	  to	  rt,	  then	  3-­‐bromoprop-­‐1-­‐ene	  (0.09ml,	  
1.05mmol)	   	   	  was	  added.	  The	  reaction	  mixture	  was	  stirred	  under	  reflux	  overnight.	  The	  reaction	  was	  
cooled	  and	  EtOAc	  was	  added,	  then	  water	  was	  carefully	  added.	  The	  aq.	  layer	  was	  extracted	  with	  EtOAc	  
(3x).	   The	   organics	   were	   then	   separated,	   washed	   with	   brine	   and	   dried	   over	   MgSO4	   before	  
concentration	   to	   dryness.	   The	   crude	   was	   then	   purified	   by	   flash	   column	   chromatography	   (EtOAc/	  
heptane,	  35:65).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  27a	  (283mg,	  
0.76mmol,	  87%)	  as	  a	  white	  solid.	  Compound	  27a	  was	  isolated	  as	  a	  mixture	  1:0.18	  of	  two	  rotamers.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  	  d	  7.37	  (br,	  0.18H)*,	  7.11	  (br,	  3H),	  6.97	  (br,	  0.36H)*,	  	  6.91	  -­‐	  6.86	  (m,	  2H),	  
6.83	  (d,	  J=8.4	  Hz,	  0.36H)*,	  6.59	  (dd,	  J=11.5,	  17.9	  Hz,	  1H),	  6.45	  (dd,	  J=11.5,	  17.9	  Hz,	  0.18H)*,	  5.86	  -­‐	  5.75	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(m,	  2.18H)**,	  5.58	  (dd,	  J=1.2,	  17.9	  Hz,	  0.18H)*,	  5.38	  (d,	  J=12.4	  Hz,	  0.18H)**,	  5.30	  (dd,	  J=1.6,	  11.5	  Hz,	  
1.18H)**,	  5.18	  (s,	  2H),	  5.16	  -­‐	  5.13	  (m,	  0.18H)*,	  5.10	  -­‐	  5.05	  (m,	  2.54H)**,	  4.04	  (br,	  2.36H)**,	  3.81	  (s,	  
3H),	  3.79	  (s,	  0.54H)*,	  1.38	  (br,	  10.62H)**;	  13C	  NMR	  (100	  MHz,	  CDCl3):	  δ	  159.43,	  154.83,	  145.24,	  137.09,	  
133.77,	   128.90,	   127.50,	   127.07,	   122.63,	   117.32,	   115.56,	   114.11,	   80.26,	   55.90,	   55.39,	   52.36,	   28.18;	  
broadening	  of	  peaks	  is	  due	  to	  the	  slow	  rotation	  of	  the	  carbamate	  linkage;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  




To	  a	  mixture	  of	  26b	  (160mg,	  0.58mmol)	  and	  3-­‐bromoprop-­‐1-­‐ene	  (0.10ml,	  1.16mmol)	  	  in	  DMF	  (3.5mL),	  
NaH	  (60%	  dispersion	  in	  mineral	  oil,	  45mg,	  1.16mmol)	  	  was	  added	  portionwise	  at	  0	  °C.	  The	  reaction	  
was	  then	  left	  at	  rt	  for	  2	  h.	  Once	  the	  starting	  material	  was	  completely	  consumed,	  water	  was	  added	  and	  
extraction	  was	  performed	  with	  DCM	  (3x).	  The	  organics	  were	  then	  separated,	  washed	  with	  brine	  and	  
dried	   over	  MgSO4	   before	   concentration	   to	   dryness.	   The	   crude	  was	   then	   purified	   by	   flash	   column	  
chromatography	   (EtOAc/	   heptane,	   50:50).	   The	   desired	   fractions	   were	   concentrated	   to	   dryness	   in	  
vacuo	  to	  afford	  27b	  (165mg,	  0.53mmol,	  90%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.17	  -­‐	  7.13	  (m,	  2H),	  7.13	  (s,	  1H),	  6.89	  -­‐	  6.86	  (m,	  2H),	  6.56	  (dd,	  J=11.4,	  18.0	  
Hz,	  1H),	  5.79	  -­‐	  5.71	  (m,	  2H),	  5.32	  (dd,	  J=1.2,	  11.4	  Hz,	  1H),	  5.17	  (s,	  2H),	  5.07	  (dq,	  J=1.3,	  10.0	  Hz,	  2H),	  
5.02	   (dq,	   J=1.3,	  17.0	  Hz,	  2H),	  4.11	   (br,	  2H),	  3.79	   (s,	  3H),	  1.85	   (s,	  3H);	  13C	  NMR	   (125	  MHz,	  CDCl3):	  δ	  
171.35,	  159.68,	  145.23,	  132.94,	  129.26,	  127.97,	  127.57,	  126.53,	  122.97,	  118.23,	  116.53,	  114.34,	  56.22,	  




To	   a	   mixture	   of	   26c	   (162mg,	   0.52mmol)	   and	   K2CO3	   (146mg,	   1.04mmol)	   in	   MeCN	   (3.7mL),	   3-­‐
bromoprop-­‐1-­‐ene	  (0.09ml,	  1.04mmol)	  was	  added.	  The	  final	  mixture	  was	  heated	  under	  reflux	  for	  2h.	  
Then,	  a	  saturated	  solution	  of	  NH4Cl	  was	  added	  and	  extraction	  was	  carried	  out	  with	  EtOAc	  (3x).	  The	  
combined	  organics	  were	  washed	  with	  brine	  and	  dried	  over	  MgSO4	  before	  concentration	  to	  dryness.	  
The	  crude	  was	  then	  purified	  by	  flash	  column	  chromatography	  (EtOAc/	  heptane,	  40:60).	  The	  desired	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fractions	  were	  concentrated	  to	  dryness	   in	  vacuo	  to	  afford	  27c	   (170mg,	  0.49mmol,	  93%)	  as	  a	  white	  
solid.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  	  δ	  7.33	  (s,	  1H),	  7.18	  -­‐	  7.14	  (m,	  2H),	  6.89-­‐6.85	  (m,	  2H),	  6.63	  (dd,	  J=11.4,	  17.9	  
Hz,	  1H),	  5.97	  (dd,	  J=1.5,	  17.9	  Hz,	  1H),	  5.86	  -­‐	  5.74	  (m,	  1H),	  5.35	  (dd,	  J=1.5,	  11.4	  Hz,	  1H),	  5.16	  (s,	  2H),	  
5.14	  -­‐	  5.06	  (m,	  2H),	  4.06	  (d,	  J=6.6	  Hz,	  2H),	  3.79	  (s,	  3H),	  2.86	  (s,	  3H);	  13C	  NMR	  (100	  MHz,	  CDCl3):	  δ	  159.67,	  
146.51,	  132.76,	  129.89,	  129.45,	  127.39,	  126.18,	  119.55,	  118.55,	  116.74,	  114.32,	  56.33,	  55.32,	  54.12,	  
39.09;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  348.1417	  [M+H]+,	  Rt	  =	  3.2	  min.	  
	  
tert-­‐butyl	  2-­‐(4-­‐methoxybenzyl)-­‐2,5-­‐dihydro-­‐4H-­‐pyrazolo[4,3-­‐b]pyridine-­‐4-­‐carboxylate	  (28a)	  
	  
A	  flask	  with	  27a	  (283mg,	  0.76mmol)	  27a	   in	  DCM	  (70mL)	  was	  degassed	  and	  backfilled	  with	  nitrogen	  
three	   times.	   Then,	   Grubb's	   catalyst	   2nd	   generation	   (32mg,	   0.038mmol)	   was	   added	   and	   the	   final	  
solution	  was	  heated	  at	  40	  °C	  for	  2	  h.	  Upon	  completion,	  DCM	  was	  removed	  and	  the	  crude	  was	  purified	  
by	  flash	  column	  chromatography	  (EtOAc/	  heptane,	  45:55).	  The	  desired	  fractions	  were	  concentrated	  
to	  dryness	   in	  vacuo	  to	  afford	  28a	   (193mg,	  0.56mmol,	  73%)	  as	  a	  colourless	  oil.	  Compound	  28a	  was	  
isolated	  as	  a	  mixture	  0.7:0.3	  of	  two	  rotamers.	  
¹H-­‐NMR	  (500	  MHz,	  DMSO-­‐d6):	  	  δ	  7.55	  (br,	  0.3H)*,	  7.25	  (br,	  0.7H),	  7.20	  -­‐	  7.13	  (br,	  2H)**,	  6.89	  (m,	  Hz,	  
2H)**,	  6.75	  -­‐	  6.64	  (br,	  1H)**,	  5.81	  (br,	  1H)**,	  5.20	  (s,	  2H)**,	  4.41	  (br,	  1H)**,	  4.34	  (br,	  1H)**,	  3.72	  (s,	  
3H)**,	   1.48	   (s,	   9H)**;	   13C	   NMR	   (125	  MHz,	   DMSO-­‐d6):	   δ	   159.21,	   152.13,	   129.72,	   129.44,	   129.33,	  
129.19,	   129.00,	   129.38,	   123.72,	   121.07,	   115.04,	   114.77,	   114.39,	   81.28,	   80.68,	   55.54,	   55.36,	   52.28,	  
46.32,	  45.20,	  28.40,	  27.88;	  broadening	  of	  peaks	  is	  due	  to	  the	  slow	  rotation	  of	  the	  carbamate	  linkage;	  




A	  flask	  with	  27b	  (165mg,	  0.53mmol)	  in	  DCM	  (48mL)	  	  was	  degassed	  and	  backfilled	  with	  nitrogen	  three	  
times.	  Then,	  Grubb's	  catalyst	  2nd	  generation	  (30mg,	  0.035mmol)	  was	  added	  and	  the	  final	  solution	  was	  
heated	  at	  40	  °C	   for	  2	  h.	  Upon	  completion,	  DCM	  was	  removed	  and	  the	  crude	  was	  purified	  by	   flash	  
column	  chromatography	  (MeOH/	  DCM,	  2:98).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  
vacuo	  to	  afford	  28b	   (105mg,	  0.37mmol,	  70%)	  as	  a	  colourless	  oil.	  Compound	  28b	  was	   isolated	  as	  a	  
mixture	  1:0.2	  of	  two	  rotamers.	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¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.91	  (d,	  J=0.6	  Hz,	  1H),	  7.21	  -­‐	  7.17	  (m,	  2.4H)**,	  6.99	  (d,	  J=0.6	  Hz,	  0.2H)*,	  
6.89	  -­‐	  6.83	  (m,	  2.4H)**,	  6.61-­‐6.59	  (m,	  0.2H)*,	  6.57	  (ddt,	  J=0.6,	  2.4,	  10.1	  Hz	  1H),	  5.92	  (td,	  J=3.9,	  10.0	  
Hz,	  0.2H)*,	  5.74	  (td,	  J=3.7,	  10.0	  Hz,	  1H),	  5.15	  (s,	  0.2H)*,	  5.10	  (s,	  2H),	  4.50	  (dd,	  J=2.4,	  3.7	  Hz,	  2.4H)**,	  
3.79	  (s,	  0.6H)*,	  3.77	  (s,	  3H),	  2.19	  (s,	  0.6H)*,	  2.14	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  168.70,	  167.96,	  
159.60,	   159.39,	   140.59,	   138.62,	   129.72,	   129.16,	   128.60,	   128.12,	   125.62,	   122.38,	   121.61,	   120.20,	  
119.62,	  119.05,	  118.99,	  114.41,	  114.31,	  114.17,	  55.96,	  55.64,	  55.29,	  47.43,	  43.72,	  22.98,	  22.29;	  LC-­‐




A	  flask	  with	  27c	  (170mg,	  0.49mmol)	  in	  DCM	  (40mL)	  was	  degassed	  and	  backfilled	  with	  nitrogen	  three	  
times.	  Then,	  Grubb's	  catalyst	  2nd	  generation	  (25.5mg,	  0.025mmol)	  was	  added	  and	  the	  final	  solution	  
was	  heated	  at	  40	  °C	  for	  2	  h.	  Upon	  completion,	  DCM	  was	  removed	  and	  the	  crude	  was	  purified	  by	  flash	  
column	  chromatography	  (EtOAc/	  heptane,	  50:50).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  
in	  vacuo	  to	  afford	  28c	  (120mg,	  0.38mmol,	  78%)	  as	  a	  colourless	  oil.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.35	  (d,	  J=0.6	  Hz,	  1H),	  7.21	  -­‐	  7.19	  (m,	  2H),	  6.88	  -­‐	  6.86	  (m,	  2H),	  6.66	  (dtd,	  
J=0.6,	  2.0,	  10.0,	  1H),	  5.82	  (td,	  J=4.0,	  10.0	  Hz,	  1H),	  5.13	  (s,	  2H),	  4.38	  (dd,	  J=2.0,	  4.0	  Hz,	  2H),	  3.79	  (s,	  3H),	  
2.72	   (s,	  3H);	   13C	  NMR	   (125	  MHz,	  CDCl3):	  δ	  159.64,	  140.96,	  129.39,	  127.88,	  122.89,	  122.30,	  120.45,	  





A	  0.05	  M	  solution	  of	  28a	  (193mg,	  0.56mmol)	  in	  EtOH	  (11ml)	  was	  hydrogenated	  in	  H-­‐cube.	  Initially,	  the	  
parameters	  (temperature:	  25°C,	  pressure:	  15bar	  and	  flowrate:	  0.5ml/min)	  were	  selected	  on	  H-­‐cube	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (3.5ml)	   and	   anisole	   (0.23ml,	   3.36mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  
volatiles	  were	  evaporated	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  
sample	  was	   filtered	   and	   injected	   in	   an	  AutoPurification	  HPLC/MS	   system	  and	  purified	  under	  basic	  
conditions.	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  to	  provide	  5a	  (38mg,	  0.30mmol,	  53%)	  
as	  a	  colourless	  oil.	  
S16	  
	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.09	  (s,	  1H),	  3.10-­‐3.07	  (m,	  2H),	  2.70	  (t,	  J=6.5	  Hz,	  2H),	  1.95	  -­‐	  1.90	  (m,	  2H);	  
13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  135.96,	  128.04,	  122.83,	  44.49,	  24.00,	  21.60;	  broadening	  of	  peaks	  is	  due	  
to	  tautomerism;	  HRMS	  (ESI):	  [M+H]+	  calcd.	  for	  C6H9N3:	  124.0869,	  found:	  124.0878.	  
	  
	  1-­‐(2,5,6,7-­‐tetrahydro-­‐4H-­‐pyrazolo[4,3-­‐b]pyridin-­‐4-­‐yl)ethan-­‐1-­‐one	  (5b)	  
	  
	  
A	  0.05	  M	  solution	  of	  28b	  (105mg,	  0.37mmol)	  in	  EtOH	  (7.5ml)	  was	  hydrogenated	  in	  H-­‐cube.	  Initially,	  
the	  parameters	  (temperature:	  25°C,	  pressure:	  15bar	  and	  flowrate:	  0.5ml/min)	  were	  selected	  on	  H-­‐
cube	  and	  a	  10%	  Pd/C	  CatCart	  was	  fitted	  in	  the	  instrument.	  After	  pumping	  pure	  EtOH	  for	  10	  min,	  the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (3.2ml)	   and	   anisole	   (0.18ml,	   2.22mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  
volatiles	  were	  evaporated	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  
sample	  was	   filtered	   and	   injected	   in	   an	  AutoPurification	  HPLC/MS	   system	  and	  purified	  under	  basic	  
conditions.	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  to	  provide	  5b	  (40mg,	  0.24mmol,	  65%)	  
as	  a	  white	  solid.	  Compound	  5b	  was	  isolated	  as	  a	  mixture	  1:0.15	  of	  two	  rotamers.	  
¹H-­‐NMR	  (400	  MHz,	  MeOD4):	  δ	  8.09	  (s,	  1H),	  7.55	  (s,	  0.15H)*,	  3.78	  -­‐	  3.74	  (m,	  2.3H)**,	  2.78	  (t,	  J=6.0	  Hz,	  
0.3H)*,	  2.75	  (t,	  J=6.3	  Hz,	  2H),	  2.32	  (s,	  0.3H),	  2.23	  (s,	  2H),	  2.08	  -­‐	  2.01	  (m,	  2H),	  1.99	  -­‐	  1.92	  (m,	  0.3	  H)*;	  
13C	  NMR	   (100	  MHz,	  MeOD4):	   δ	   168.58,	   136.90,	   123.14,	   119.93,	   45.76,	   42.02,	   22.24,	   22.12,	   21.90,	  




A	  0.05	  M	  solution	  of	  28c	  (120mg,	  0.38mmol)	  in	  EtOH	  (7.5ml)	  was	  hydrogenated	  in	  H-­‐cube.	  Initially,	  
the	  parameters	  (temperature:	  25°C,	  pressure:	  15bar	  and	  flowrate:	  0.5ml/min)	  were	  selected	  on	  H-­‐
cube	  and	  a	  10%	  Pd/C	  CatCart	  was	  fitted	  in	  the	  instrument.	  After	  pumping	  pure	  EtOH	  for	  10	  min,	  the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (3.2ml)	   and	   anisole	   (0.18ml,	   2.22mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  
volatiles	  were	  evaporated	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  
sample	  was	   filtered	   and	   injected	   in	   an	  AutoPurification	  HPLC/MS	   system	  and	  purified	  under	  basic	  
conditions.	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  to	  provide	  5c	  (55mg,	  0.27mmol,	  71%)	  
as	  a	  white	  solid.	  
S17	  
	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.55	  (s,	  1H),	  3.65	  -­‐	  3.62	  (m,	  2H),	  2.85	  (s,	  3H),	  2.75	  (t,	  J=6.4	  Hz,	  2H),	  2.05	  
-­‐	  1.99	   (m,	  2H);	   13C	  NMR	   (125	  MHz,	  MeOD4):	  δ	  137.64,	  124.16,	  121.49,	  47.60,	  35.45,	  22.97,	  21.30;	  




To	  a	  solution	  of	  25	  (155mg,	  0.67mmol)	  and	  pyridine	  (0.08ml,	  1.0mmol)	  in	  DCM	  (2.5mL)	  at	  0	  oC	  ,	  prop-­‐
2-­‐ene-­‐1-­‐sulfonyl	  chloride	  (0.07ml,	  0.67mmol)	  was	  added	  and	  the	  mixture	  was	  stirred	  for	  1	  h.	  Then,	  a	  
saturated	  solution	  of	  NH4Cl	  was	  added	  and	  the	  two	  layers	  were	  separated.	  The	  aq.	  layer	  was	  further	  
extracted	  with	   DCM	   (2x).	   The	   combined	   organics	  were	  washed	  with	   brine	   and	   dried	   over	  MgSO4	  
before	   concentration	   to	   dryness.	   	   The	   crude	   was	   then	   purified	   by	   flash	   column	   chromatography	  
(EtOAc/	  heptane,	  30:70).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	   in	  vacuo	  to	  afford	  29	  
(200mg,	  0.60mmol,	  89%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.41	  (s,	  1H),	  7.20	  -­‐	  7.17	  (m,	  2H),	  6.88	  -­‐	  6.85	  (m,	  2H),	  6.61	  (dd,	  J=11.4,	  17.8	  
Hz,	  1H),	  6.27	  (br,	  1H),	  5.90	  (dd,	  J=1.4,	  17.8	  Hz,	  1H),	  5.87-­‐5.79	  (m,	  1H),	  5.39	  (dq,	  J=10.2,	  1.1	  Hz,	  1H),	  
5.34	  (dd,	  J=1.4,	  11.4	  Hz,	  1H),	  5.32	  (dq,	  J=17.0,	  1.1	  Hz),	  5.14	  (s,	  2H),	  3.79	  (s,	  3H),	  3.70	  (td,	  J=1.0,	  7.3	  Hz,	  
2H);	   13C	  NMR	   (125	  MHz,	  CDCl3):	  δ	  159.68,	  143.92,	  129.52,	  127.53,	  127.05,	  125.72,	  125.14,	  124.42,	  
116.67,	  115.76,	  114.33,	  56.30,	  55.59,	  55.33;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  334.1229	  [M+H]+,	  Rt	  =	  3.0	  
min	  
	  
2-­‐(4-­‐methoxybenzyl)-­‐2,6-­‐dihydro-­‐4H-­‐pyrazolo[4,3-­‐c][1,2]thiazepine	  5,5-­‐dioxide	  (30)	  
	  
A	  flask	  with	  29	  (200mg,	  0.60mmol)	  in	  DCM	  (60mL)	  was	  degassed	  and	  backfilled	  with	  nitrogen	  three	  
times.	  Then,	  Grubb's	  catalyst	  2nd	  (25mg,	  0.03mmol)	  was	  added	  and	  the	  final	  solution	  was	  heated	  at	  
40	   °C	   for	   2	   h.	   Upon	   completion,	   DCM	  was	   removed	   and	   the	   crude	  was	   purified	   by	   flash	   column	  
chromatography	   (EtOAc/	   heptane,	   40:60).	   The	   desired	   fractions	   were	   concentrated	   to	   dryness	   in	  
vacuo	  to	  afford	  30	  (153mg,	  0.5mmol,	  83%)	  as	  a	  colourless	  oil.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.26	  (d,	  J=0.7	  Hz,	  1H),	  7.09	  -­‐	  7.06	  (m,	  2H),	  6.87	  -­‐	  6.84	  (m,	  2H),	  6.72	  (dq,	  
J=11.7,	  0.8	  Hz,	  1H),	  5.73	  (td,	  J=5.8,	  11.6	  Hz,	  1H),	  5.32	  (s,	  2H),	  4.11	  (dd,	  J=1.3,	  5.8	  Hz,	  2H),	  3.75	  (s,	  3H);	  
13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  160.93,	  132.76,	  132.57,	  130.16,	  129.25,	  120.59,	  120.43,	  120.35,	  115.24,	  




2,6,7,8-­‐tetrahydro-­‐4H-­‐pyrazolo[4,3-­‐c][1,2]thiazepine	  5,5-­‐dioxide	  (6)	  
	  
A	  0.05	  M	  solution	  of	  30	  (153mg,	  0.5mmol)	  in	  EtOH	  (13ml)	  was	  hydrogenated	  in	  H-­‐cube.	  Initially,	  the	  
parameters	  (temperature:	  25°C,	  pressure:	  15bar	  and	  flowrate:	  0.5ml/min)	  were	  selected	  on	  H-­‐cube	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (4ml)	   and	   anisole	   (0.23ml,	   3mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  
volatiles	  were	  evaporated	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  
sample	  was	   filtered	   and	   injected	   in	   an	  AutoPurification	  HPLC/MS	   system	  and	  purified	  under	  basic	  
conditions.	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  to	  provide	  6	  (52mg,	  0.28mmol,	  56%)	  
as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  8.49	  (s,	  1H),	  7.45	  (s,	  1H),	  3.47	  -­‐	  3.43	  (m,	  2H),	  2.93	  -­‐	  2.90	  (m,	  2H),	  2.19	  -­‐	  
2.14	  (m,	  2H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  146.50,	  130.46,	  116.10,	  56.86,	  25.34,	  23.62;	  HRMS	  (ESI):	  
[M+H]+	  calcd.	  for	  C6H9N3O2S:	  188.0488,	  found:	  188.0490.	  
(1-­‐(4-­‐methoxybenzyl)-­‐4-­‐nitro-­‐1H-­‐pyrazol-­‐3-­‐yl)alanine	  (31a)	  
	  
A	  microwave	  vial	  was	  charged	  with	  2	  (340mg,	  1.14mmol),	  Cs2CO3	  (710mg,	  2.28mmol),	  CuI	  (20.4mg,	  
0.114mmol),	   alanine	   (291mg,	   3.42mmol),	   water	   (0.58ml)	   and	   DMF	   (3ml).	   The	   vial	   was	   capped	  
properly,	  and	  thereafter	  the	  mixture	  was	  heated	  under	  microwave	   irradiation	  conditions	  at	  150	  °C	  
and	  200	  W	  for	  4	  h.	  Then,	  a	  saturated	  solution	  of	  NH4Cl	  was	  added,	  and	  the	  aq.	  layer	  was	  extracted	  
with	   DCM	   (3x).	   The	   combined	   organic	   fractions	   were	   washed	   with	   brine,	   dried	   over	   MgSO4	   and	  
evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  eluting	  (EtOAc/Heptane	  
30:70).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  31b	  (250mg,	  0.78mmol,	  
69%)	  as	  a	  yellow	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ¹H	  10.70	  (s,	  1H),	  7.70	  (s,	  1H),	  7.25	  -­‐	  7.20	  (m,	  2H),	  6.91	  -­‐	  6.88	  (m,	  2H),	  6.17	  
(d,	  J=6.1	  Hz,	  1H),	  4.99	  (s,	  2H),	  4.47	  (dd,	  J=6.7,	  6.7	  Hz,	  1H),	  3.80	  (s,	  3H),	  1.58	  (d,	  J=7.2	  Hz,	  3H);	  13C	  NMR	  
(125	  MHz,	   CDCl3):	   δ160.18,	   150.23,	   130.32,	   128.50,	   125.34,	   125.29,	   121.40,	   114.58,	   56.46,	   56.43,	  






To	  a	  suspension	  of	  31b	   (250mg,	  0.78mmol)	   in	  EtOH	  (3ml)	  was	  added	   iron	  (348mg,	  6.24mmol)	  and	  
NH4Cl	   (166mg,	   3.12mmol)	   in	  water	   (0.5ml).	   The	   final	  mixture	  was	   stirred	   at	   80	   °C	   for	   48	   h.	   After	  
cooling,	  the	  mixture	  was	  neutralised	  with	  NaHCO3	  and	  filtered	  through	  celite	  eluting	  with	  DCM.	  Then,	  
volatiles	  were	  removed	   in	  vacuo	  and	  water	  added	  to	  the	  solid	  residue	  followed	  by	  DCM.	   	  The	  two	  
layers	  were	  separated	  and	  the	  aq.	  phase	  was	  extracted	  with	  DCM	  (3x).	  The	  combined	  organic	  fractions	  
were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  
column	  chromatography	  (MeOH+7N	  amonia/DCM	  5:95).	  The	  desired	  fractions	  were	  concentrated	  to	  
dryness	  in	  vacuo	  to	  afford	  32b	  (186mg,	  0.68mmol,	  87%)	  as	  a	  reddish	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  DMSO-­‐d6):	  δ	  9.76	  (s,	  1H),	  7.18-­‐7.14	  (m,	  2H),	  7.10	  (s,	  1H),	  6.89-­‐6.86	  (m,	  2H),	  5.82	  
(d,	  J=2.1	  Hz,	  1H),	  4.92	  (s,	  2H),	  3.75-­‐3.70	  (m,	  4H),	  1.22	  (d,	  J=6.7	  Hz,	  3H);	  13C	  NMR	  (125	  MHz,	  DMSO-­‐d6	  
):	  δ	  167.80,	  159.07,	  145.34,	  130.67,	  129.46,	  115.26,	  114.19,	  110.59,	  55.54,	  54.36,	  52.99,	  18.42;	  LC-­‐MS,	  




32	  (186mg,	  0.68mmol)	  was	  dissolved	  in	  TFA	  (6ml)	  and	  anisole	  (0.44ml,	  4.1mmol)	  was	  added.	  The	  final	  
mixture	  was	  stirred	  for	  12	  h	  at	  80	  °C.	  After	  cooling,	  volatiles	  were	  evaporated	  and	  the	  solid	  residue	  
was	   dissolved	   in	   MeOH/water/MeCN	   3:1:1.	   The	   latter	   sample	   was	   filtered	   and	   injected	   in	   an	  
AutoPurification	  HPLC/MS	   system	   and	   purified	   under	   basic	   conditions.	   The	   desired	   fractions	  were	  
concentrated	  to	  dryness	  to	  provide	  7	  (60mg,	  0.39mmol,	  57%)	  as	  a	  reddish	  solid.	  	  
¹H-­‐NMR	  (500	  MHz,	  DMSO-­‐d6):	  	  δ	  11.27	  (1H,	  s),	  9.77	  (1H,	  s),	  7.00	  (1H,	  s),	  5.74	  (1H,	  s),	  3.71	  (1H,	  d,	  J=4.7	  
Hz),	  1.22	  (3H,	  d,	   J=6.1	  Hz);	  13C	  NMR	   (125	  MHz	  DMSO-­‐d6):	  δ	  168.09,	  145.13,	  114.00,	  110.51,	  53.09,	  
18.47;	  HRMS	  (ESI):	  [M+H]+	  calcd.	  for	  C6H8N4O:	  153.0770,	  found:	  153.0776.	  
	  




A	  microwave	  vial	  was	  charged	  with	  2	  (210mg,	  0.67mmol),	  Cs2CO3	  (420mg,	  1.34mmol),	  CuI	  (24.4mg,	  
0.13mmol),	  2-­‐amino-­‐2-­‐methyl-­‐propanoic	  acid	  (200mg,	  2.01mmol),	  water	  (0.35ml)	  and	  DMF	  (2ml).	  The	  
vial	   was	   capped	   properly,	   and	   thereafter	   the	   mixture	   was	   heated	   under	   microwave	   irradiation	  
conditions	  at	  150	  °C	  and	  200	  W	  for	  4	  h.	  Then,	  a	  saturated	  solution	  of	  NH4Cl	  was	  added,	  and	  the	  aq.	  
layer	  was	  extracted	  with	  DCM	  (3x).	  The	  combined	  organic	  fractions	  were	  washed	  with	  brine,	  dried	  
over	  MgSO4	  and	  evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  eluting	  
(EtOAc/Heptane	  30:70).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  31b	  
(153mg,	  0.46mmol,	  68%)	  as	  a	  yellow	  solid.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  10.32	  (br,	  1H),	  7.72	  (s,	  1H),	  7.22-­‐7.19	  (m,	  2H),	  6.91	  -­‐	  6.87	  (m,	  2H),	  6.35	  (s,	  
1H),	  4.96	  (s,	  2H),	  3.80	  (s,	  3H),	  1.70	  (s,	  6H);	  13C	  NMR	  (100	  MHz,	  CDCl3):	  δ	  180.50,	  160.09,	  149.25,	  130.35,	  
130.18,	  127.97,	  125.65,	  121.90,	  114.59,	  114.52,	  57.69,	  56.48,	  55.35,	  25.26;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  




To	  a	  suspension	  of	  31b	  (153mg,	  0.46mmol)	  in	  EtOH	  (1.4ml)	  was	  added	  iron	  (205mg,	  3.68mmol)	  and	  
NH4Cl	   (98mg,	   1.84mmol)	   in	  water	   (0.25ml).	   The	   final	  mixture	  was	   stirred	   at	   80	   °C	   for	   48	   h.	   After	  
cooling,	  the	  mixture	  was	  neutralised	  with	  NaHCO3	  and	  filtered	  through	  celite	  eluting	  with	  DCM.	  Then,	  
volatiles	  were	  removed	   in	  vacuo	  and	  water	  added	  to	  the	  solid	  residue	  followed	  by	  DCM.	   	  The	  two	  
layers	  were	  separated	  and	  the	  aq.	  phase	  was	  extracted	  with	  DCM	  (3x).	  The	  combined	  organic	  fractions	  
were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  
column	  chromatography	  (MeOH+7N	  amonia/DCM	  5:95).	  The	  desired	  fractions	  were	  concentrated	  to	  
dryness	  in	  vacuo	  to	  afford	  32b	  (115mg,	  0.4mmol,	  89%)	  as	  a	  reddish	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.17	  -­‐	  7.13	  (m,	  3H),	  7.10	  (s,	  1H),	  6.88	  -­‐	  6.85	  (m,	  2H),	  5.11	  (s,	  2H),	  3.79	  (s,	  
3H),	  3.05	  (s,	  1H),	  1.31	  (s,	  6H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  169.30,	  159.44,	  131.81,	  128.73,	  128.32,	  
124.58,	  114.30,	  111.79,	  57.17,	  55.32,	  51.80,	  25.22;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  287.1531	  [M+H]+,	  Rt	  




32	  (115mg,	  0.4mmol)	  was	  dissolved	  in	  TFA	  (3.5ml)	  and	  anisole	  (0.26ml,	  2.4mmol)	  was	  added.	  The	  final	  
mixture	  was	  stirred	  for	  12	  h	  at	  80	  °C.	  After	  cooling,	  volatiles	  were	  evaporated	  and	  the	  solid	  residue	  
was	   dissolved	   in	   MeOH/water/MeCN	   3:1:1.	   The	   latter	   sample	   was	   filtered	   and	   injected	   in	   an	  
S21	  
	  
AutoPurification	  HPLC/MS	   system	   and	   purified	   under	   basic	   conditions.	   The	   desired	   fractions	  were	  
concentrated	  to	  dryness	  to	  provide	  7	  (37mg,	  0.22mmol,	  55%)	  as	  a	  reddish	  solid.	  	  
¹H-­‐NMR	  (400	  MHz,	  MeOD4):	  	  δ	  6.98	  (s,	  1H),	  1.25	  (s,	  6H);	  13C	  NMR	  (100	  MHz,	  MeOD4):	  δ	  171.34,	  144.58,	  
114.03,	  109.64,	  56.56,	  24.50;	  HRMS	  (ESI):	  [M+H]+	  calcd.	  for	  C7H10N4O:	  167.0927,	  found:	  167.0936.	  
	  
3-­‐((1-­‐(4-­‐methoxybenzyl)-­‐4-­‐nitro-­‐1H-­‐pyrazol-­‐3-­‐yl)amino)-­‐2-­‐methylpropanoic	  acid	  (33)	  
	  
A	  microwave	  vial	  was	  charged	  with	  2	  (610mg,	  1.95mmol),	  Cs2CO3	  (1280mg,	  3.9mmol),	  CuI	  (73.2mg,	  
0.39mmol),	  3-­‐amino-­‐2-­‐methyl-­‐propanoic	  acid	  (610mg,	  5.85mmol),	  water	  (1ml)	  and	  DMF	  (6ml).	  The	  
vial	   was	   capped	   properly,	   and	   thereafter	   the	   mixture	   was	   heated	   under	   microwave	   irradiation	  
conditions	  at	  150	  °C	  and	  200	  W	  for	  4	  h.	  Then,	  saturated	  solution	  of	  NH4Cl	  was	  added,	  and	  the	  aq.	  layer	  
was	  extracted	  with	  DCM	  (3x).	  The	  combined	  organic	   fractions	  were	  washed	  with	  brine,	  dried	  over	  
MgSO4	   and	   evaporated	   in	   vacuo.	   The	   crude	   was	   purified	   by	   flash	   column	   chromatography	  
(EtOAc/Heptane	  30:70).	   The	  desired	   fractions	  were	   concentrated	   to	  dryness	   in	   vacuo	   to	  afford	  33	  
(460mg,	  1.37mmol,	  70%)	  as	  a	  yellow	  solid.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  7.69	  (s,	  1H),	  7.26-­‐7.23	  (m,	  2H),	  6.93-­‐6.89	  (m,	  2H),	  6.00	  (d,	  J=7.9	  Hz,	  1H),	  
5.02	  (s,	  2H),	  4.21	  (ddq,	  J=5.0,	  6.7,	  7.1	  Hz,	  1H),	  3.82	  (s,	  3H),	  2.83	  (dd,	  J=5.0,	  15.8	  Hz,	  1H),	  2.58	  (dd,	  J=7.1,	  
15.8	  Hz,	  1H),	  1.39	  (d,	  J=6.7	  Hz);	  13C	  NMR	  (100	  MHz,	  CDCl3):	  δ	  176.66,	  160.19,	  150.42,	  130.40,	  128.30,	  
125.30,	   121.34,	   114.59,	   56.48,	   55.38,	   45.46,	   40.44,	   20.54;	   LC-­‐MS,	   6	  min	   run,	   (ESI+)	  m/z	   335.1370	  




To	  a	  suspension	  of	  33	  (460mg,	  1.37mmol)	  in	  EtOH	  (7ml)	  was	  added	  iron	  (615mg,	  10.9mmol)	  and	  NH4Cl	  
(297mg,	  5.5mmol)	  in	  water	  (1.4ml).	  The	  final	  mixture	  was	  stirred	  at	  80°	  C	  for	  48	  h.	  After	  cooling,	  the	  
mixture	  was	  neutralised	  with	  NaHCO3	  and	  filtered	  through	  celite	  eluting	  with	  DCM.	  Then,	  volatiles	  
were	  removed	  in	  vacuo	  and	  water	  added	  to	  the	  solid	  residue	  followed	  by	  DCM.	  	  The	  two	  layers	  were	  
separated	   and	   the	   aq.	   phase	  was	   extracted	  with	   DCM	   (3x).	   The	   combined	   organic	   fractions	  were	  
washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  column	  
chromatography	  (MeOH+7N	  amonia/DCM	  5:95).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  
in	  vacuo	  to	  afford	  34	  (264mg,	  0.92mmol,	  67%)	  as	  a	  reddish	  solid.	  
S22	  
	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  8.99	  (s,	  1H),	  7.14-­‐7.11	  (m,	  2H),	  6.95	  (s,	  1H),	  6.86	  -­‐	  6.83	  (m,	  2H),	  4.91	  (s,	  
2H),	  4.23	  (br,	  1H),	  3.78-­‐3.73	  (m,	  4H),	  2.65	  (d,	  J=5.2	  Hz,	  2H),	  1.28	  (d,	  J=6.4	  Hz,	  3H);	  13C	  NMR	  (125	  MHz,	  
CDCl3):	  δ	  172.67,	  159.45,	  146.44,	  129.18,	  128.34,	  128.24,	  120.01,	  114.19,	  107.85,	  55.30,	  47.35,	  45.01,	  




34	  (264mg,	  0.92mmol)	  was	  dissolved	  in	  TFA	  (8.4ml)	  and	  anisole	  (0.39ml,	  5.52mmol)	  was	  added.	  The	  
final	  mixture	  was	   stirred	   for	   12	   h	   at	   80	   °C.	   After	   cooling,	   volatiles	  were	   evaporated	   and	   the	   solid	  
residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  sample	  was	  filtered	  and	  injected	  in	  an	  
AutoPurification	  HPLC/MS	   system	   and	   purified	   under	   basic	   conditions.	   The	   desired	   fractions	  were	  
concentrated	  to	  dryness	  to	  provide	  8	  (80mg,	  0.48mmol,	  52%)	  as	  a	  reddish	  solid.	  	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.20	  (s,	  1H),	  3.76	  -­‐	  3.69	  (m,	  1H),	  2.66	  -­‐	  2.59	  (m,	  2H),	  1.28	  (d,	  J=6.6	  Hz,	  
3H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  172.91,	  144.62,	  122.85,	  106.28,	  47.20,	  44.38,	  21.64;	  HRMS	  (ESI):	  
[M+H]+	  calcd.	  for	  C7H10N4O:	  167.0927,	  found:	  167.0930.	  
1-­‐(4-­‐methoxybenzyl)-­‐4-­‐nitro-­‐1H-­‐pyrazol-­‐3-­‐ol	  (35)	  
	  
A	  microwave	   vial	   was	   charged	  with	   2	   (575mg,	   1.85mmol)	   Cs2CO3	   (1800mg,	   5.55mmol),	   Pd2(dba)3	  
(84.5mg,	  0.092mmol),	  tBuBrettPhos	  (15.5mg,	  0.18mmol),	  water	  (0.32ml)	  and	  DMF	  (8.5mL).	  	  The	  vial	  
was	  capped	  properly,	  and	  thereafter	  the	  mixture	  was	  heated	  under	  microwave	  irradiation	  conditions	  
at	  130	   °C	  and	  200	  W	   for	  1	  h.	  Then,	   saturated	  solution	  of	  NH4Cl	  was	  added,	  and	   the	  aq.	   layer	  was	  
extracted	  with	  DCM	  (3x).	  The	  combined	  organic	  fractions	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  
and	  evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  (EtOAc/Heptane	  
45:55).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  35	  (260mg,	  0.96mmol,	  
52%)	  as	  a	  pale	  yellow	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  	  δ	  8.16	  (s,	  1H),	  7.73	  (s,	  1H),	  7.27—7.24	  (m,	  1H),	  6.94-­‐6.91	  (m,	  2H),	  5.06	  (s,	  
2H),	  3.82	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  160.40,	  156.25,	  130.49,	  129.79,	  127.57,	  124.74,	  114.73,	  
57.01,	  55.40;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  272.0662	  [M+Na]+,	  Rt	  =	  2.5	  min.	  
	  




To	   a	   mixture	   of	   35	   (104mg,	   0.38mmol)	   and	   K2CO3	   (66mg,	   0.48mmol)	   in	   DMF	   (1.5mL),	   ethyl	   2-­‐
bromopropanoate	  (0.062ml,	  0.48mmol)	  was	  added	  at	  0	  °C.	  After	  2h,	  water	  was	  added	  and	  extraction	  
was	  carried	  out	  with	  DCM	  (3x).	   	  The	  organics	  were	  then	  washed	  with	  brine	  and	  dried	  over	  MgSO4	  
before	   concentration	   to	   dryness.	   The	   crude	   was	   then	   purified	   by	   flash	   column	   chromatography	  
(EtOAc/	  heptane,	  30:70).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	   in	  vacuo	  to	  afford	  36	  
(128mg,	  0.36mmol,	  93%)	  as	  an	  orange	  oil.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  	  δ	  7.80	  (s,	  1H),	  7.20	  -­‐	  7.18	  (m,	  2H),	  6.91	  -­‐	  6.88	  (m,	  2H),	  5.11	  (q,	  J=7.0	  Hz,	  
1H),	  4.98	  (s,	  2H),	  4.17	  (q,	  J=7.1	  Hz,	  2H),	  3.81	  (s,	  3H),	  1.67	  (d,	  J=7.0	  Hz,	  3H),	  1.20	  (t,	  J=7.1	  Hz,	  3H);	  13C	  
NMR	   (125	  MHz,	   CDCl3):	   δ	   170.92,	   160.21,	   154.83,	   130.17,	   129.86,	   125.30,	   121.18,	   114.56,	   61.24,	  




To	  a	  suspension	  of	  36	   (128mg,	  0.36mmol)	   in	  EtOH	  (2ml)	  was	  added	  iron	  (163.6mg,	  2.88mmol)	  and	  
NH4Cl	   (78mg,	   1.44mmol)	   in	  water	   (0.30ml).	   The	   final	  mixture	  was	   stirred	   at	   80	   °C	   for	   24	   h.	   After	  
cooling,	  the	  mixture	  was	  neutralised	  with	  NaHCO3	  and	  filtered	  through	  celite	  eluting	  with	  DCM.	  Then,	  
volatiles	  were	  removed	   in	  vacuo	  and	  water	  added	  to	  the	  solid	  residue	  followed	  by	  DCM.	   	  The	  two	  
layers	  were	  separated	  and	  the	  aq.	  phase	  was	  extracted	  with	  DCM	  (3x).	  The	  combined	  organic	  fractions	  
were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  
column	  chromatography	  (EtOAc/Heptane	  40:60).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  
in	  vacuo	  to	  afford	  37	  (82mg,	  0.30mmol,	  82%)	  as	  a	  reddish	  oil.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  8.77	  (s,	  1H),	  7.18	  (m,	  2H),	  6.87	  (m,	  2H),	  6.84	  (s,	  1H),	  4.99	  (s,	  2H),	  4.77	  (q,	  
J=6.9	  Hz,	  1H),	  3.79	  (s,	  3H),	  1.58	  (d,	  J=6.9	  Hz,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  167.02,	  159.60,	  150.35,	  
129.52,	  128.03,	  115.02,	  114.23,	  107.94,	  55.83,	  55.32,	  17.12;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  274.1202	  






37	  (82mg,	  0.30mmol)	  was	  dissolved	  in	  TFA	  (2.6ml)	  and	  anisole	  (0.128ml,	  1.80mmol)	  was	  added.	  The	  
final	  mixture	  was	   stirred	   for	   12	   h	   at	   80	   °C.	   After	   cooling,	   volatiles	  were	   evaporated	   and	   the	   solid	  
residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  sample	  was	  filtered	  and	  injected	  in	  an	  
AutoPurification	  HPLC/MS	   system	   and	   purified	   under	   basic	   conditions.	   The	   desired	   fractions	  were	  
concentrated	  to	  dryness	  to	  provide	  9	  (32mg,	  0.20mmol,	  66%)	  as	  a	  pinkish	  solid.	  
¹H-­‐NMR	  (400	  MHz,	  MeOD4):	  δ	  7.15	  (s,	  1H),	  4.76	  (q,	  J=6.9	  Hz,	  1H),	  1.51	  (d,	  J=6.9	  Hz,	  3H);	  13C	  NMR	  (100	  
MHz,	   MeOD4):	   δ	   166.78,	   114.55,	   107.55,	   75.58,	   16.07;	   HRMS	   (ESI):	   [M+H]+	   calcd.	   for	   C6H7N3O2:	  
154.0611,	  found:	  154.0612.	  
	  
ethyl	  (E)-­‐3-­‐((1-­‐(4-­‐methoxybenzyl)-­‐4-­‐nitro-­‐1H-­‐pyrazol-­‐3-­‐yl)oxy)but-­‐2-­‐enoate	  (38)	  
	  
To	  a	  flask	  was	  added	  DABCO	  (85mg,	  0.76mmol)	  and	  35	  (206mg,	  0.76mmol).	  The	  flask	  was	  evacuated	  
then	  placed	  under	  a	  N2	  atmosphere.	  MeCN	  (1ml)	  was	  charged	  and	  the	  resulting	  solution	  heated	  to	  70	  
°C.	  Ethyl	  but-­‐2-­‐ynoate	  (0.051ml,	  0.76mmol)	  was	  added	  and	  the	  resulting	  mixture	  stirred	  at	  70	  °C	  for	  1	  
h.	  The	  reaction	  mixture	  was	  diluted	  with	  EtOAc	  and	  then	  cooled	  to	  0	  °C	  in	  an	  ice	  bath.	  1	  M	  HCl	  aq.	  
solution	   was	   added	   dropwise	   and	   the	   biphasic	   mixture	   allowed	   to	   warm	   to	   rt.	   The	   phases	   were	  
separated	  and	  the	  organic	  layer	  was	  washed	  sequentially	  with	  1	  M	  NaOH	  aq.	  solution	  and	  water	  (2×).	  
The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  (EtOAc/Heptane	  25:75).	  The	  desired	  fractions	  
were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  38	  (254mg,	  0.70mmol,	  92%)	  as	  a	  yellow	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  	  δ	  7.92	  (s,	  1H),	  7.29-­‐7.26	  (m,	  2H),	  6.96-­‐6.93	  (m,	  2H),	  5.18	  (q,	  J=0.7	  Hz,	  1H),	  
5.14	  (s,	  2H),	  4.13	  (q,	  J=7.1	  Hz,	  4H),	  3.83	  (s,	  3H),	  2.52	  (d,	  J=0.7	  Hz,	  3H),	  1.24	  (t,	  J=7.1	  Hz,	  3H);	  13C	  NMR	  
(125	  MHz,	  CDCl3):	  δ	  169.70,	  166.49,	  160.49,	  150.34,	  130.47,	  129.97,	  124.56,	  123.85,	  114.82,	  98.89,	  






A	  0.05	  M	  solution	  of	  38	  (254mg,	  0.70mmol)	  in	  EtOH	  (12ml)	  and	  1,4-­‐dioxane	  (2ml)	  was	  hydrogenated	  
in	  H-­‐cube.	   Initially,	   the	  parameters	   (temperature:	   80°C,	   pressure:	   80bar,	   and	   flowrate:	   0.5ml/min)	  
were	  selected	  on	  H-­‐cube	  and	  a	  10%	  Pd/C	  CatCart	  was	  fitted	  in	  the	  instrument.	  After	  pumping	  pure	  
EtOH	  for	  10	  min,	  the	  injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  
and	  the	  hydrogenation	  process	  was	  started	  (3	  cycles).	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  
completion	   (complete	   reduction	  of	   the	  double	  bond	  and	  partial	   reduction	  of	   the	  nitro	  group),	   the	  
reaction	  was	  concentrated	  up	  to	  0.3M,	  iron	  (197mg,	  3.5mmol)	  and	  NH4Cl	  (113mg,	  2.1mmol)	  in	  water	  
(0.5ml)	  was	  added	  and	  the	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  24	  h.	  After	  cooling,	  the	  mixture	  was	  
neutralised	  with	  NaHCO3	  and	  filtered	  through	  celite	  eluting	  with	  DCM.	  Then,	  volatiles	  were	  removed	  
in	  vacuo	  and	  water	  added	  to	  the	  solid	  residue	  followed	  by	  DCM.	  	  The	  two	  layers	  were	  separated	  and	  
the	  aq.	  phase	  was	  extracted	  with	  DCM	  (3x).	  The	  combined	  organic	  fractions	  were	  washed	  with	  brine,	  
dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  
eluting	  (EtOAc/Heptane	  40:60).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  
39	  (131mg	  ,	  0.45mmol,	  64%)	  as	  a	  reddish	  oil.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  9.01	  (s,	  1H),	  7.21-­‐7.17	  (m,	  2H),	  6.99	  (s,	  1H),	  6.87	  -­‐	  6.84	  (m,	  2H),	  4.96	  (s,	  
2H),	  4.59-­‐4.52	  (m,	  1H),	  3.78	  (s,	  3H),	  2.86	  (dd,	  J=7.4,	  16.2	  Hz,	  1H),	  2.78	  (d,	  J=16.2	  Hz,	  1H),	  1.46	  (d,	  J=6.4	  
Hz,	  3H);	  13C	  NMR	  (100	  MHz,	  CDCl3):	  δ	  171.97,	  159.60,	  151.31,	  129.58,	  127.82,	  119.42,	  114.21,	  106.50,	  




39	  (131mg,	  0.45mmol)	  was	  dissolved	  in	  TFA	  (4ml)	  and	  anisole	  (0.24ml,	  2.7mmol)	  was	  added.	  The	  final	  
mixture	  was	  stirred	  for12h	  at	  80	  °C.	  After	  cooling,	  volatiles	  were	  evaporated	  and	  the	  solid	  residue	  was	  
dissolved	   in	   MeOH/water/MeCN	   3:1:1.	   The	   latter	   sample	   was	   filtered	   and	   injected	   in	   an	  
AutoPurification	  HPLC/MS	   system	   and	   purified	   under	   basic	   conditions.	   The	   desired	   fractions	  were	  
concentrated	  to	  dryness	  to	  provide	  10	  (42mg,	  0.25mmol,	  55%)	  as	  a	  pinkish	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.27	  (s,	  1H),	  4.60	  (ddq,	  J=1.7,	  6.4,	  7.1	  Hz,	  1H),	  2.85	  (dd,	  J=7.1,	  16.2	  Hz,	  
1H),	  2.79	  (dd,	  J=1.7,	  16.2	  Hz,	  1H),	  1.43	  (d,	  J=6.4	  Hz,	  3H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  173.32,	  121.37,	  
107.21,	   73.16,	   21.56;	   broadening	   of	   peaks	   is	   due	   to	   tautomerism;	  HRMS	   (ESI):	   [M+H]+	   calcd.	   for	  




ethyl	  (E)-­‐3-­‐(1-­‐(4-­‐methoxybenzyl)-­‐4-­‐nitro-­‐1H-­‐pyrazol-­‐3-­‐yl)acrylate	  (40)	  
	  
A	  mixture	  of	  2	  (470mg,	  1.5mmol),	  Pd(dppf)Cl2  (110	  mg,	  0.15	  mmol),	  Cs2CO3	  (970mg,	  3mmol),	  and	  ethyl	  
(2E)-­‐3-­‐(4,4,5,5-­‐tetramethyl,3,2-­‐dioxaborolan-­‐2-­‐yl)acrylate	  (500mg,	  2.25	  mmol)	   in	  DMF	  (4.7ml)	  were	  
sealed	  in	  a	  vial	  and	  subjected	  to	  microwave	  irradiation	  at	  145	  °C	  and	  200W	  for	  45	  min.	  The	  reaction	  
mixture	  was	  diluted	  with	  water	  and	  EtOAc.	  The	  organic	  solution	  was	  separated	  and	  washed	  with	  brine,	  
dried	  over	  MgSO4	  and	  concentrated.	  The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  eluting	  
(EtOAc/Heptane	  20:80).	   The	  desired	   fractions	  were	   concentrated	   to	  dryness	   in	   vacuo	   to	  afford	  40	  
(335mg,	  1.07mmol,	  71%)	  as	  a	  pale	  yellow	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  8.07	  (d,	  J=16.0	  Hz,	  1H),	  8.00	  (s,	  1H),	  7.29	  -­‐	  7.26	  (m,	  2H),	  6.95	  -­‐	  6.92	  (m,	  
2H),	  6.86	  (d,	  J=16.0	  Hz,	  1H),	  5.22	  (s,	  2H),	  4.28	  (q,	  J=7.2	  Hz,	  2H),	  3.83	  (s,	  3H),	  1.34	  (t,	  J=7.2	  Hz,	  3H);	  13C	  
NMR	   (125	  MHz,	  CDCl3):	  δ	  166.16,	  160.36,	  142.31,	  133.62,	  131.25,	  130.27,	  130.01,	  125.15,	  124.27,	  
114.74,	  60.84,	  57.27,	  55.40,	  14.28;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  332.1259	  [M+H]+,	  Rt	  =	  3.8	  min.	  
	  
ethyl	  2,3-­‐dihydroxy-­‐3-­‐(1-­‐(4-­‐methoxybenzyl)-­‐4-­‐nitro-­‐1H-­‐pyrazol-­‐3-­‐yl)propanoate	  (41)	  
	  
To	  a	  mixture	  of	  40	   (355mg,	  1.07mmol)	   in	  acetone/water	  9:1	   (18ml/2ml)	  was	  added	  NMO	  (252mg,	  
2.14mmol)	   and	   the	   temperature	  was	   lowered	  up	   to	   0	   °C.	  OsO4	  (4%	  wt.	   solution	   in	  water,	   0.24ml,	  
0.34mmol)	  was	  added	  and	  the	  reaction	  allowed	  to	  reach	  rt.	  After	  stirring	  for	  24	  h,	  the	  reaction	  was	  
quenched	  by	  adding	  a	  saturated	  solution	  of	  Na2SO3	  followed	  by	  EtOAc.	  The	  two	  layers	  were	  separated	  
and	  the	  aq.	  phase	  was	  extracted	  with	  EtOAc	  (3x).	  The	  organics	  were	  washed	  with	  brine,	  dried	  over	  
MgSO4	   and	   evaporated	   in	   vacuo.	   The	   residue	   was	   purified	   by	   flash	   column	   chromatography	  
(EtOAc/Heptane	  40:60)	  to	  afford	  41	  (370mg,	  1.01	  mmol,	  94%)	  as	  a	  pale	  yellow	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.96	  (s,	  1H),	  7.26	  -­‐	  7.24	  (m,	  2H),	  6.95	  -­‐	  6.92	  (m,	  2H),	  5.61	  (d,	  J=5.3	  Hz,	  1H),	  
5.24	  (d,	  J=14.6	  Hz,	  1H),	  5.24	  (d,	  J=14.6	  Hz,	  1H),	  4.62	  (br,	  1H),	  4.36	  (q,	  J=7.1	  Hz,	  2H),	  3.83	  (s,	  3H),	  3.67	  
(d,	  J=7.8	  Hz,	  1H),	  3.30	  (br,	  1H),	  1.36	  (t,	  J=7.2	  Hz,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  172.22,	  160.38,	  
147.27,	  132.50,	  130.38,	  130.33,	  125.02,	  114.78,	  72.29,	  69.15,	  62.52,	  56.98,	  55.40,	  14.18;	  LC-­‐MS,	  6	  min	  
run,	  (ESI+)	  m/z	  366.1301	  [M+H]+,	  Rt	  =	  2.7	  min.	  
	  




To	   a	   stirred	   solution	   of	   41	   (370mg,	   1.01	   mmol)	   in	   pyridine	   (20mL),	   was	   added	   thionyl	   chloride	  
(0.087mL,	  1.21mmol)	  dropwise	  under	  nitrogen	  atmosphere	  at	  0	  °C	  and	  allowed	  to	  stir	  at	  0	  °C	  for	  30	  
min.	  The	  reaction	  mixture	  was	  quenched	  by	  the	  addition	  of	  cold	  water	  and	  a	  saturated	  solution	  of	  
NH4Cl.	  The	  organic	   layer	  was	   separated	  and	   the	  aqueous	   layer	  was	  extracted	  with	  DCM	  (2	  x).	  The	  
organics	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo.	  The	  residue	  was	  purified	  
by	  flash	  column	  chromatography	  (EtOAc/Heptane	  20:80)	  to	  afford	  42	  (412mg,	  0.96	  mmol,	  95%)	  as	  a	  
pale	  yellow	  oil.	  42	  was	  isolated	  as	  two	  diastereomeric	  pairs	  of	  enantiomers.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  	  δ	  8.02	  (s,	  1H),	  7.98	  (s,	  1H),	  7.21-­‐7.23	  (m,	  4H),	  6.95	  -­‐	  6.92	  (m,	  4H),	  6.76	  (d,	  
J=6.4	  Hz,	  1H),	  6.29	  (d,	  J=6.4	  Hz,	  1H),	  6.09	  (d,	  J=6.4	  Hz,	  1H),	  5.47	  (d,	  J=6.4	  Hz,	  1H),	  5.25	  (s,	  2H),	  5.23	  (s,	  
2H),	  4.34	  -­‐	  4.28	  (m,	  4H),	  3.83	  (s,	  3H),	  3.82	  (s,	  3H),	  1.30	  (t,	  J=7.1	  Hz,	  6H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  
166.77,	   166.52,	   160.49,	   160.43,	   141.63,	   141.14,	   133.76,	   133.53,	   130.48,	   130.37,	   130.33,	   124.90,	  
124.74,	  114.83,	  114.79,	  80.54,	  78.64,	  77.92,	  76.36,	  62.96,	  62.88,	  57.33,	  57.28,	  55.41,	  55.40;	  LC-­‐MS,	  6	  




To	  the	  stirred	  solution	  of	  42	  (412mg,	  0.96mmol)	  and	  CoCl2・6H2O	  (2.3mg,	  0.009mmol)	  in	  EtOH	  (3mL),	  
NaBH4	  (152mg,	  3.84mmol)	  was	  added	  at	  0	  °C	  and	  allowed	  to	  stir	  for	  12	  h	  at	  25	  °C.	  After	  completion	  of	  
reaction,	   it	   was	   poured	   into	   ice	   cold	   water.	   To	   the	   aqueous	   layer,	   ethyl	   acetate	   was	   added	   and	  
combined	  mixture	  was	  passed	  through	  celite.	  The	  organic	  layer	  was	  separated	  and	  the	  aq.	  layer	  was	  
extracted	  with	  ethyl	  acetate	  (2x).	  Combined	  organic	  layers	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  
and	  concentrated	  under	  reduced	  pressure.	  The	  crude	  was	  injected	  in	  an	  AutoPurification	  HPLC/MS	  
system	  and	  purified	  under	  basic	  conditions.	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  to	  
provide	  43	  (63mg,	  0.24mmol,	  25%)	  as	  a	  yellow	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  	  δ	  ,	  7.19	  -­‐	  7.16	  (m,	  2H),	  6.87	  -­‐	  6.85	  (m,	  2H),	  6.81	  (s,	  1H),	  5.09	  (s,	  2H),	  4.27	  -­‐	  
4.24	  (m,	  1H),	  3.79	  (s,	  3H),	  3.18	  (ddd,	  J=1.2,	  5.2,	  11.7	  Hz,	  1H),	  3.10	  (d,	  J=11.0	  Hz,	  2H),	  3.01	  (dd,	  J=4.6,	  
16.4	  Hz,	  1H),	  2.83	  (ddd,	  J=0.8,	  3.9,	  16.4	  Hz,	  1H),	  2.27	  (d,	  J=7.3	  Hz,	  1H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  
159.44,	  136.42,	  129.25,	  128.98,	  127.46,	  115.02,	  114.20,	  64.42,	  55.66,	  55.29,	  48.67,	  31.19;	  LC-­‐MS,	  6	  






43	  (63mg,	  0.24mmol)	  was	  dissolved	  in	  TFA	  (2.2mL)	  and	  anisole	  (0.025mL,	  1.44mmol)	  was	  added.	  The	  
final	  mixture	  was	   stirred	   for	   12	   h	   at	   80	   °C.	   After	   cooling,	   volatiles	  were	   evaporated	   and	   the	   solid	  
residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  sample	  was	  filtered	  and	  injected	  in	  an	  
AutoPurification	  HPLC/MS	   system	   and	   purified	   under	   basic	   conditions.	   The	   desired	   fractions	  were	  
concentrated	  to	  dryness	  to	  provide	  11	  (18mg,	  0.13mmol,	  53%)	  as	  a	  pale	  yellow	  oil.	  
¹H-­‐NMR	  (400	  MHz,	  MeOD4):	  δ	  7.10	  (d,	  J=1.2	  Hz,	  1H),	  4.17	  -­‐	  4.08	  (m,	  1H),	  3.12	  (d,	  J=11.7	  Hz,	  1H),	  3.01	  
(d,	  J=5.1	  Hz,	  1H),	  2.95-­‐2.99	  (m,	  1H),	  2.64	  (dd,	  J=6.5,	  16.0	  Hz,	  1H);	  13C	  NMR	  (100	  MHz,	  MeOD3):	  δ	  133.76,	  
125.82,	  120.41,	  64.28,	  48.93,	  29.44;	  broadening	  of	  peaks	  is	  due	  to	  tautomerism;	  HRMS	  (ESI):	  [M+H]+	  




A	   flask	   was	   charged	   with	   3	   (640mg,	   2.16mmol),	   CsF	   (660mg,	   4.32mmol),	   Pd(t-­‐Bu3P)2	   (55.3mg,	  
0.11mmol)	   	   and	   THF	   (11.2mL)	   under	   nitrogen	   atmosphere.	   Then,	   tributyl(vinyl)stannane	   (0.77ml,	  
2.59mmol)	  was	  added	  and	  the	  final	  mixture	  was	  stirred	  at	  rt	  for	  24h.	  Subsequently,	  the	  reaction	  was	  
diluted	  with	  Et2O	  and	  water	  was	  added.	  The	  two	  layers	  were	  separated	  and	  the	  aq.	  one	  was	  extracted	  
further	  with	  Et2O	  (2x).	  The	  combined	  organics	  were	  washed	  with	  brine	  and	  dried	  over	  MgSO4	  before	  
concentration	  to	  dryness.	  The	  crude	  was	  passed	  through	  celite	  eluting	  with	  DCM	  and	  then	  purified	  by	  
flash	  column	  chromatography	  eluting	  30%EtOAc	  in	  heptane.	  The	  desired	  fractions	  were	  concentrated	  
to	  dryness	  in	  vacuo	  to	  afford	  44	  (450mg,	  1.69mmol,	  78%)	  as	  a	  pale	  yellow	  oil.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  9.87	  (s,	  1H),	  7.73	  (s,	  1H),	  7.26	  -­‐	  7.22	  (m,	  2H),	  7.00	  (dd,	  J=11.3,	  17.7	  Hz,	  
1H),	  6.91	  -­‐	  6.89	  (m,	  2H),	  6.18	  (dd,	  J=1.7,	  17.7	  Hz,	  1H),	  5.49	  (dd,	  J=1.7,	  11.3	  Hz,	  1H),	  5.21	  (s,	  2H),	  3.80	  -­‐	  
3.80	  (m,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  159.98,	  150.72,	  134.55,	  129.95,	  126.67,	  126.43,	  121.30,	  






To	   a	   solution	   of	   44	   (450mg,	   1.69mmol)	   in	   DCM	   (6ml)	   was	   added	  MgSO4	   (795mg,	   6.76mmol)	   and	  
propyilamine	  (0.2ml,	  2.53mmol),	  and	  the	  reaction	  was	  stirred	  at	  rt	  for	  24	  h.	  Then,	  the	  mixture	  was	  
filtered	  and	  volatiles	  were	  evaporated	  in	  vacuo.	  The	  solid	  residue	  was	  dissolved	  in	  MeOH	  (12ml)	  and	  
NaBH4	  (23mg,	  0.51mmol)	  was	  added	  at	  0	  °C.	  The	  reaction	  was	  stirred	  at	  0	  °C	  for	  1h.	  Afterwards,	  water	  
was	  added	  followed	  by	  EtOAc.	  The	  two	  layers	  were	  separated	  and	  the	  aq.	  phase	  was	  extracted	  with	  
EtOAc	  (3x).	  The	  combined	  organic	  fractions	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  
in	  vacuo.	  The	  residue	  was	  purified	  by	  flash	  column	  chromatography	  (MeOH/DCM	  4:96)	  to	  afford	  45	  
(430mg,	  1.5	  mmol,	  89%)	  as	  a	  white	  solid.	  	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.26	  -­‐	  7.21	  (m,	  3H),	  6.91	  -­‐	  6.89	  (m,	  2H),	  6.78	  (dd,	  J=11.4,	  17.9	  Hz,	  1H),	  
5.99	  -­‐	  5.90	  (m,	  1H),	  5.85	  (dd,	  J=1.6,	  17.9	  Hz,	  1H),	  5.34	  (dd,	  J=1.6,	  11.4	  Hz,	  1H),	  5.24	  -­‐	  5.20	  (m,	  3H),	  5.14	  
(qd,	  J=1.4,	  10.3	  Hz,	  1H),	  3.81	  (s,	  3H),	  3.73	  (s,	  2H),	  3.31	  (td,	  J=1.4,	  6.0	  Hz,	  2H),	  1.38	  (s,	  1H);	  13C	  NMR	  (125	  
MHz,	   CDCl3):	   δ	   159.45,	   147.53,	   136.70,	   129.37,	   129.14,	   128.31,	   128.15,	   118.69,	   116.09,	   115.28,	  
114.16,	  55.53,	  55.25,	  52.06,	  43.01;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  284.1778	  [M+H]+,	  Rt	  =	  2.1	  min.	  
	  
tert-­‐butyl	  allyl((1-­‐(4-­‐methoxybenzyl)-­‐3-­‐vinyl-­‐1H-­‐pyrazol-­‐4-­‐yl)methyl)carbamate	  (46a)	  
	  
To	  a	  solution	  of	  45	   (140mg,	  0.5mmol)	  and	   	  Et3N	  (0.083ml,	  0.59mmol)	   in	  DCM	  (45mL)	  at	  0	  oC	   ,	  Boc	  
anhydride	  (139mg,	  0.64mmol)	  was	  added	  and	  the	  reaction	  was	   left	  under	  stirring	  at	  25	  oC	  for	  1	  h.	  
Then,	  a	  saturated	  solution	  of	  NH4Cl	  was	  added	  and	  the	  two	  layers	  were	  separated.	  The	  aq.	  layer	  was	  
further	   extracted	  with	   DCM	   (2x).	   The	   combined	   organics	  were	  washed	  with	   brine	   and	   dried	   over	  
MgSO4	  before	  concentration	  to	  dryness.	  The	  crude	  was	  then	  purified	  by	  flash	  column	  chromatography	  
(EtOAc/	  heptane,	  35:65).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  46a	  
(180mg,	  0.46mmol,	  92%)	  as	  a	  yellow	  solid.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ,	  7.19	  -­‐	  7.15	  (m,	  3H),	  6.88-­‐6.84	  (m,	  2H),	  6.68	  (dd,	  J=11.4,	  17.8	  Hz,	  1H),	  5.79	  
(d,	  J=17.8	  Hz,	  1H),	  5.68	  (br,	  1H),	  5.26	  (dd,	  J=1.5,	  11.4	  Hz,	  1H),	  5.17	  (s,	  2H),	  5.09	  (br,	  2H),	  4.29	  (s,	  2H),	  
3.78	  (s,	  3H),	  3.71	  (s,	  2H),	  1.42	  (s,	  9H);	  13C	  NMR	  (100	  MHz,	  CDCl3):	  δ	  159.50,	  155.22,	  147.81,	  133.84,	  
129.99,	  129.37,	  128.19,	  127.45,	  116.65,	  115.47,	  114.21,	  79.79,	  55.64,	  55.30,	  48.05,	  39.19,	  28.38;	  LC-­‐






To	  a	  solution	  of	  45	  (180mg,	  0.63mmol)	  and	  	  pyridine	  (0.28ml,	  1.26mmol)	  in	  THF	  (2mL)	  at	  0	  oC	  ,	  acetyl	  
chloride	  (0.19ml,	  0.95mmol)	  was	  added	  and	  the	  reaction	  was	  left	  under	  stirring	  at	  0	  oC	  for	  1	  h.	  Then,	  
a	  saturated	  solution	  of	  NH4Cl	  was	  added	  and	  the	  two	  layers	  were	  separated.	  The	  aq.	  layer	  was	  further	  
extracted	  with	   DCM	   (2x).	   The	   combined	   organics	  were	  washed	  with	   brine	   and	   dried	   over	  MgSO4	  
before	   concentration	   to	   dryness.	   The	   crude	   was	   then	   purified	   by	   flash	   column	   chromatography	  
(MeOH/	   DCM,	   2:98).	   The	   desired	   fractions	   were	   concentrated	   to	   dryness	   in	   vacuo	   to	   afford	   46b	  
(177mg,	  0.54mmol,	  85%)	  as	  a	  yellow	  solid.	  46b	  was	  isolated	  as	  a	  mixture	  1:0.4	  of	  two	  rotamers.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  7.22	  (s,	  1H),	  7.18-­‐7.14	  (m,	  2.8H)**,	  7.07	  (s,	  0.4H)*,	  6.88	  -­‐	  6.84	  (m,	  2.8H)**,	  
6.71-­‐6.60	  (m,	  1.4H)**,	  5.82	  (dd,	  J=1.6,	  17.7	  Hz,	  1H),	  5.77	  -­‐	  5.62	  (m,	  1.8H)**,	  5.32	  (dd,	  J=0.9,	  11.5	  Hz,	  
0.4H)*,	  5.26	  (dd,	  J=1.6,	  11.3	  Hz,	  1H),	  5.19	  -­‐	  5.04	  (m,	  5.6H)**,	  4.45	  (s,	  2H),	  4.37	  (s,	  0.8H)*,	  3.95	  (d,	  J=5.7	  
Hz,	  0.8H)*,	  3.79	  (s,	  1.2H)*,	  3.78	  (s,	  3H),	  3.77-­‐3.74	  (m,	  2H),	  2.10	  (s,	  1.2H)*,	  2.06	  (s,	  3H);	  13C	  NMR	  (100	  
MHz,	   CDCl3):	   δ	   170.61,	   170.37,	   159.58,	   159.48,	   147.95,	   147.09,	   133.03,	   132.55,	   130.39,	   129.35,	  
129.30,	   128.21,	   128.18,	   127.93,	   127.72,	   127.16,	   117.47,	   116.66,	   116.16,	   115.80,	   115.67,	   114.28,	  
114.19,	  55.83,	  55.67,	  55.30,	  49.40,	  47.53,	  42.75,	  37.85,	  21.48;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  326.1864	  




To	   a	   mixture	   of	   45	   (110mg,	   0.38mmol)	   and	   pyridine	   (0.062ml,	   0.76mmol)	   in	   DCM	   (1mL),	  
methanesulfonyl	   chloride	   (0.044ml,	  0.57mmol)	   	   	   	  was	  added	  at	  0	   °C.	   The	  mixture	  was	   stirred	  at	  0	  
°C	  for	  2	  h.	  Then,	  a	  saturated	  solution	  of	  NH4Cl	  was	  added	  and	  the	  two	  layers	  were	  separated.	  The	  aq.	  
layer	  was	  further	  extracted	  with	  DCM	  (2x).	  	  	  The	  combined	  organics	  were	  washed	  with	  brine	  and	  dried	  
over	  MgSO4	  before	  concentration	  to	  dryness	  to	  afford	  46c	  (132mg,	  0.36mmol,	  93%)	  as	  a	  yellow	  solid.	  
The	  solid	  was	  pure	  enough	  to	  be	  used	  in	  the	  next	  step	  without	  further	  purification.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  	  δ	  7.30	  (s,	  1H),	  7.19-­‐7.16	  (m,	  2H),	  6.8-­‐6.85	  (m,	  2H),	  6.70	  (dd,	  J=11.3,	  17.7	  
Hz,	  1H),	  5.87	  (dd,	  J=1.6,	  17.7	  Hz,	  1H),	  5.82	  -­‐	  5.70	  (m,	  1H),	  5.32	  (dd,	  J=1.6,	  11.3	  Hz,	  1H),	  5.24	  -­‐	  5.17	  (m,	  
4H),	  4.29	  (s,	  2H),	  3.79	  (s,	  3H),	  3.74	  (d,	  J=6.2	  Hz,	  2H),	  2.77	  (s,	  3H);	  13C	  NMR	  (100	  MHz,	  CDCl3):	  δ	  159.57,	  
S31	  
	  
148.02,	  132.41,	  130.57,	  129.33,	  128.02,	  126.81,	  119.36,	  116.22,	  114.25,	  114.21,	  55.80,	  55.31,	  48.72,	  




A	  0.05	  M	  solution	  of	  46a	  (180mg,	  0.46mmol)	  in	  DCM	  (46ml)	  was	  degassed	  and	  backfilled	  with	  nitrogen	  
3	  times.	  Then,	  Grubbs’	  catalyst	  2nd	  generation	  (19mg,	  0.023mmol)	  was	  added	  to	  the	  reaction	  mixture	  
and	   temperature	  was	   raised	   up	   to	   40	   °C.	   After	   3	   h,	   the	   reaction	  was	   cooled	   down	   and	  DCM	  was	  
removed	   in	   vacuo.	   The	   solid	   residue	   was	   purified	   by	   flash	   column	   chromatography	   eluting	  
(EtOAc/Heptane	  45:65).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  47a	  
(with	  Boc)	  (130mg,	  0.36mmol,	  77%)	  as	  a	  white	  solid.	  A	  small	  amount	  of	  the	  latter	  was	  deprotected	  by	  
using	   TFA	   in	   DCM,	   in	   order	   to	   get	  more	   comprehensible	   NMR	   spectra.	   LC-­‐MS	   values	   of	   both	   the	  
protected	  and	  deprotected	  version	  are	  reported.	  
¹H-­‐NMR	  (without	  Boc)	  (500	  MHz,	  CDCl3):	  δ	  ,	  7.19	  -­‐	  7.16	  (m,	  2H),	  6.99	  (s,	  1H),	  6.89	  -­‐	  6.85	  (m,	  2H),	  6.52	  
(dt,	  J=11.9,	  1.7	  Hz,	  1H),	  5.83	  (dt,	  J=11.9,	  4.0	  Hz,	  1H),	  5.13	  (s,	  2H),	  3.89	  (s,	  2H),	  3.79	  (s,	  3H),	  3.73	  (dd,	  
J=1.7,	  4.0	  Hz,	  2H);	   13C	  NMR	   (without	  Boc)	   (125	  MHz,	  DMSO-­‐d6):	  δ	  159.49,	  148.69,	  132.77,	  129.27,	  
128.50,	   126.15,	   123.33,	   121.84,	   114.21,	   55.39,	   55.30,	   52.32,	   45.42;	   LC-­‐MS,	   6	  min	   run,	   (ESI+)	  m/z	  




A	  0.05	  M	  solution	  of	  46b	  (177mg,	  0.54mmol)	  in	  DCM	  (54ml)	  was	  degassed	  and	  backfilled	  with	  nitrogen	  
3	  times.	  Then,	  Grubbs’	  catalyst	  2nd	  generation	  (14mg,	  0.027mmol)	  was	  added	  to	  the	  reaction	  mixture	  
and	   temperature	  was	   raised	   up	   to	   40	   °C.	   After	   3	   h,	   the	   reaction	  was	   cooled	   down	   and	  DCM	  was	  
removed	   in	   vacuo.	   The	   solid	   residue	   was	   purified	   by	   flash	   column	   chromatography	   eluting	  
(MeOH/DCM	   3:97).	   The	   desired	   fractions	   were	   concentrated	   to	   dryness	   in	   vacuo	   to	   afford	   47b	  
(123mg,	  0.41mmol,	  75%)	  as	  a	  white	  solid.	  47b	  was	  isolated	  as	  a	  mixture	  1:0.8	  of	  two	  rotamers.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ,	  7.15-­‐7.11	  (m,	  3.6H)**,	  7.11	  (s,	  1H),	  7.08	  (s,	  0.8H)*,	  6.85-­‐6.80	  (m,	  3.6H)**,	  
6.55	  (td,	  J=1.7,	  11.9	  Hz,	  1H),	  6.45	  (td,	  J=1.8,	  11.8	  Hz,	  0.8H)*,	  5.80-­‐5.73	  (m,	  1.8H)**,	  5.11	  (s,	  1.6H)*,	  
5.07	  (s,	  2H),	  4.56	  (s,	  2H),	  4.42	  (s,	  1.6H)*,	  4.35	  (d,	  J=3.9	  Hz,	  1.6H)*,	  4.20	  (d,	  J=4.0	  Hz,	  2H),	  3.75	  (s,	  2.4H)*,	  
3.74	  (s,	  3H),	  2.05	  (s,	  3H),	  1.99	  (s,	  2.4H)*;	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  170.08,	  169.97,	  159.54,	  159.50,	  
148.38,	   147.64,	   129.42,	   129.28,	   128.49,	   128.10,	   128.04,	   127.38,	   126.09,	   125.97,	   124.38,	   122.16,	  
S32	  
	  
118.55,	  117.79,	  114.25,	  114.21,	  55.50,	  55.29,	  51.13,	  47.85,	  45.83,	  42.57,	  21.17.21.13;	  LC-­‐MS,	  6	  min	  




A	  0.05	  M	  solution	  of	  46c	   (132mg,	  0.36mmol)	   in	  DCM	  was	  degassed	  and	  backfilled	  with	  nitrogen	  3	  
times.	  Then,	  Grubbs’	  catalyst	  2nd	  generation	  (9.2mg,	  0.018mmol)	  was	  added	  to	  the	  reaction	  mixture	  
and	   temperature	  was	   raised	   up	   to	   40	   °C.	   After	   3	   h,	   the	   reaction	  was	   cooled	   down	   and	  DCM	  was	  
removed	   in	   vacuo.	   The	   solid	   residue	   was	   purified	   by	   flash	   column	   chromatography	   eluting	  
(EtOAc/Heptane	  50:50).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	   in	  vacuo	  to	  afford	  47c	  
(97mg,	  0.29mmol,	  79%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ,	  7.18	  -­‐	  7.15	  (m,	  3H),	  6.88	  -­‐	  6.86	  (m,	  2H),	  6.62	  (ddt,	  J=0.7,	  1.8,	  12.0	  Hz,	  1H),	  
5.74	  (dt,	  J=4.0,	  12.0	  Hz,	  1H),	  5.15	  (s,	  2H),	  4.53	  (d,	  J=0.6	  Hz,	  2H),	  4.36-­‐4.34	  (m,	  2H),	  3.79	  (s,	  3H),	  2.57	  (s,	  
3H);	   13C	  NMR	   (125	  MHz,	  CDCl3):	  δ	  159.67,	  147.92,	  129.30,	  127.83,	  127.32,	  126.86,	  123.52,	  117.85,	  




A	  0.05	  M	  solution	  of	  47a	  (130mg,	  0.36mmol)	  in	  EtOH	  (7ml)	  was	  hydrogenated	  in	  H-­‐cube.	  Initially,	  the	  
parameters	  (temperature:	  25°C,	  pressure:	  15bar	  and	  flowrate:	  0.5ml/min)	  were	  selected	  on	  H-­‐cube	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (3.6ml)	   and	   anisole	   (0.24ml,	   2.2mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  
the	  volatiles	  were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  
The	   latter	   sample	  was	  directly	   injected	   in	  an	  AutoPurification	  HPLC/MS	  system	  and	  purified	  under	  
basic	  conditions.	  The	  desired	  fractions	  were	  evaporated	  to	  provide	  13a	  (25mg,	  0.18mmol,	  49%)	  as	  a	  
white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.38	  (s,	  1H),	  3.82	  (s,	  2H),	  3.19-­‐3.16	  (m,	  2H),	  2.88	  -­‐	  2.84	  (m,	  2H),	  1.84	  -­‐	  
1.78	   (m,	   2H);	   13C	   NMR	   (125	  MHz,	  MeOD4):	   δ	   150.33,	   132.20,	   120.00,	   53.62,	   45.30,	   29.82,	   28.16;	  







A	   0.05	  M	   solution	   of	  47b	   (123mg,	   0.41mmol)	   in	   EtOH	   (41ml)	  was	   hydrogenated	   in	   an	  H-­‐cubePro.	  
Initially,	  the	  parameters	  (temperature:	  25°C,	  pressure:	  15bar	  and	  flowrate:	  0.5ml/min)	  were	  selected	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (3.7ml)	   and	   anisole	   (0.27ml,	   2.46mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  
the	  volatiles	  were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  
The	  latter	  sample	  was	  filtered	  and	  injected	  in	  an	  AutoPurification	  HPLC/MS	  system	  and	  purified	  under	  
basic	  conditions.	  The	  desired	  fractions	  were	  evaporated	  to	  provide	  13b	  (40mg,	  0.22mmol,	  53%)	  as	  a	  
white	  solid.	  Compound	  13b	  was	  isolated	  as	  a	  mixture	  1:0.7	  of	  two	  rotamers.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.52	  (s,	  1H),	  7.42	  (s,	  0.7H)*,	  4.49	  (s,	  1.4H)*,	  4.47	  (s,	  2H),	  3.83-­‐3.79	  (m,	  
3.4H)**,	  2.93-­‐2.90	  (m,	  1.4H)*,	  2.89-­‐2.86	  (m,	  2H),	  2.08	  (s,	  2.1H)*,	  2.07	  (s,	  3H),	  1.88-­‐1.84	  (m,	  1.4H)*,	  
1.82	  -­‐	  1.76	  (m,	  2H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  172.61,	  172.12,	  150.00,	  149.91,	  132.22,	  131.84,	  
118.12,	   117.85,	   53.62,	   50.53,	   46.19,	   42.30,	   29.25,	   27.67,	   26.63,	   27.59,	   21.63,	   21.52;	  HRMS	   (ESI):	  




A	   0.05	  M	   solution	   of	   47c	   (97mg,	   0.29mmol)	   in	   EtOH	   (29ml)	   was	   hydrogenated	   in	   an	   H-­‐cubePro.	  
Initially,	  the	  parameters	  (temperature:	  25°C,	  pressure:	  15bar	  and	  flowrate:	  0.5ml/min)	  were	  selected	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (2.6ml)	   and	   anisole	   (0.19ml,	   1.74mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  
the	  volatiles	  were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  
The	  latter	  sample	  was	  filtered	  and	  injected	  in	  an	  AutoPurification	  HPLC/MS	  system	  and	  purified	  under	  
basic	  conditions.	  The	  desired	  fractions	  were	  evaporated	  to	  afford	  13c	  (36mg,	  0.16mmol,	  55%)	  as	  a	  
white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.45	  (s,	  1H),	  4.39	  (s,	  2H),	  3.72	  -­‐	  3.69	  (m,	  2H),	  2.93	  -­‐	  2.90	  (m,	  2H),	  2.74	  
(s,	  3H),	  1.92	  -­‐	  1.86	  (m,	  2H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  116.48,	  51.45,	  43.43,	  37.84,	  27.11,	  26.05;	  






To	  a	  solution	  of	  3	   (955mg,	  3.24mmol)	   in	  DCM	  (10ml)	  was	  added	  MgSO4	  (1525mg,	  12.96mmol)	  and	  
propyilamine	  (0.35ml,	  4.86mmol),	  and	  the	  reaction	  was	  stirred	  at	  rt	  for	  24	  h.	  Then,	  the	  mixture	  was	  
filtered	  and	  volatiles	  were	  evaporated	   in	  vacuo.	  The	  solid	  residue	  was	  dissolved	   in	  MeOH	  (ml)	  and	  
NaBH4	  (240mg,	  6.48mmol)	  was	  added	  at	  0	  °C.	  The	  reaction	  was	  stirred	  at	  0	  °C	  for	  1	  h.	  Afterwards,	  
water	  was	  added	  followed	  by	  EtOAc.	  The	  two	  layers	  were	  separated	  and	  the	  aq.	  phase	  was	  extracted	  
with	   EtOAc	   (3x).	   The	   combined	   organic	   fractions	  were	   washed	  with	   brine,	   dried	   over	  MgSO4	  and	  
evaporated	  in	  vacuo.	  The	  residue	  was	  purified	  by	  flash	  column	  chromatography	  (MeOH/DCM	  3:97)	  to	  
afford	  48	  (1.03	  g,	  3.05	  mmol,	  94%)	  as	  a	  yellow	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.19	  -­‐	  7.17	  (m,	  3H),	  6.87	  -­‐	  6.84	  (m,	  2H),	  5.91	  -­‐	  5.83	  (m,	  1H),	  5.16	  (qd,	  J=1.7,	  
17.1	  Hz,	  1H),	  5.13	  (s,	  2H),	  5.09	  (qd,	  J=1.4,	  10.2	  Hz,	  1H),	  3.78	  (s,	  3H),	  3.56	  (s,	  2H),	  3.22	  (td,	  J=1.4,	  6.0	  Hz,	  
2H),	  1.35	  (s,	  1H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  159.69,	  136.50,	  129.66,	  129.53,	  127.48,	  126.09,	  120.06,	  
116.23,	   114.29,	   56.19,	   55.31,	   51.73,	   42.84;	   LC-­‐MS,	   6	  min	   run,	   (ESI+)	  m/z	   336.0175	   ([M+H]+,	   79Br),	  
338.0602	  ([M+H]+,	  81Br)	  Rt	  =	  2.3	  min.	  
	  
tert-­‐butyl	  allyl((3-­‐bromo-­‐1-­‐(4-­‐methoxybenzyl)-­‐1H-­‐pyrazol-­‐4-­‐yl)methyl)carbamate	  (49a)	  
	  
To	  a	  solution	  of	  48	  (375mg,	  1.2mmol),	  DMAP	  (6.75mg,	  0.06mmol)	  and	  Et3N	  (0.23ml,	  1.8mmol)	  in	  THF	  
(mL),	  Boc	  anhydride	  (363mg,	  1.8mmol)	  was	  added	  at	  0	  °C.	  After	  stirring	  at	  rt	   for	  12	  h,	  a	  saturated	  
solution	  NH4Cl	  was	  added.	  The	  two	  layers	  were	  separated	  and	  the	  aq.	  phase	  was	  further	  extracted	  
with	   DCM	   (2x).	   The	   combined	   organic	   fractions	   were	   washed	   with	   brine,	   dried	   over	   MgSO4	   and	  
evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  (EtOAc/Heptane	  30:70).	  
The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  49a	  (452mg,	  1.03mmol,	  92%)	  
as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.34	  (br,	  0.6H),	  7.18	  (d,	  J=8.0	  Hz,	  2H),	  7.11	  (br,	  0.4H)*,	  6.86	  (d,	  J=8.0	  Hz,	  
2H),	  5.71	  (br,	  1H),	  5.13	  (s,	  2H),	  5.09	  (br,	  2H),	  4.12	  (br,	  2H),	  3.78	  (s,	  3H),	  3.76	  (br,	  2H),	  1.42	  (s,	  9H);	  13C	  
NMR	   (125	  MHz,	  CDCl3):	  δ	  159.74,	  155.23,	  133.72,	  130.89,	  129.68,	  127.31,	  126.25,	  118.81,	  116.60,	  
114.31,	  79.77,	  56.26,	  55.40,	  48.87,	  40.06,	  28.39;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  436.0800	  ([M+H]+,	  79Br),	  






To	   a	   solution	   of	   48	   (332mg,	   0.98mmol)	   and	   pyridine	   (0.15ml,	   1.47mmol)	   in	   DCM	   (3.2mL),	   acetyl	  
chloride	  (0.11ml,	  1.96mmol)	  was	  added	  at	  0	  °C.	  After	  stirring	  at	  0	  °C	  for	  1	  h,	  a	  saturated	  solution	  NH4Cl	  
was	  added.	  The	  two	  layers	  were	  separated	  and	  the	  aq.	  phase	  was	  further	  extracted	  with	  DCM	  (2x).	  
The	  combined	  organic	  fractions	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo.	  
The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  (EtOAc/Heptane	  60:40).	  The	  desired	  fractions	  
were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  49b	  (335mg,	  0.88mmol,	  89%)	  as	  a	  white	  solid.	  49b	  
was	  isolated	  as	  a	  mixture	  1:0.3	  of	  two	  rotamers.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.30	  (s,	  1H),	  7.10	  (s,	  0.3H)*,	  7.11	  -­‐	  7.06	  (m,	  2.6H)**,	  6.77-­‐6.73	  (m,	  2.6H)**,	  
5.69	  -­‐	  5.57	  (m,	  1.3H)**,	  5.013	  -­‐	  4.99	  (m,	  5.2H)**,	  4.19	  (s,	  2H),	  4.15	  (s,	  0.6H)*,	  3.82	  (d,	  J=5.8	  Hz,	  0.6H)*,	  
3.77	  (m,	  2H),	  3.67	  (s,	  0.9H)*,	  3.65	  (s,	  3H),	  2.06	  (s,	  0.9H)*,	  1.94	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  
170.62,	   170.02,	   159.68,	   159.56,	   132.89,	   132.51,	   131.38,	   129.48,	   129.46,	   129.32,	   127.47,	   127.23,	  
126.45,	   125.30,	   118.08,	   117.39,	   117.29,	   116.72,	   114.27,	   114.17,	   56.26,	   56.14,	   55.21,	   55.20,	   50.62,	  
47.25,	   42.32,	   39.03	   21.71,	   21.28;	   LC-­‐MS,	   6	  min	   run,	   (ESI+)	  m/z	   378.0826	   ([M+H]+,	   79Br),	   380.0805	  




To	   a	   solution	   of	   48	   (320mg,	   0.95mmol)	   and	   pyridine	   (0.31ml,	   3.80mmol)	   	   in	   DCM	   (3.2mL),	  
methanesulfonyl	   chloride	   (0.22ml,	   2.85mmol)	   	  was	   added	   at	   0	   °C.	   After	   stirring	   at	   0	   °C	   for	   1	   h,	   a	  
saturated	  solution	  NH4Cl	  was	  added.	  The	  two	  layers	  were	  separated	  and	  the	  aq.	  phase	  was	  further	  
extracted	  with	  DCM	  (2x).	  The	  combined	  organic	  fractions	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  
and	  evaporated	  in	  vacuo	  to	  afford	  49c	  (361mg,	  0.87mmol,	  92	  %)	  as	  a	  yellow	  oil.	  	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.38	  (s,	  1H),	  7.19	  -­‐	  7.16	  (m,	  2H),	  6.87	  -­‐	  6.84	  (m,	  2H),	  5.82	  -­‐	  5.74	  (m,	  1H),	  
5.28	  -­‐	  5.21	  (m,	  2H),	  5.14	  (s,	  2H),	  4.17	  (s,	  2H),	  3.78-­‐3.75	  (m,	  5H),	  2.80	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  
δ	  159.76,	  132.30,	  131.40,	  129.55,	  127.30,	  126.55,	  119.39,	  116.82,	  114.35,	  56.42,	  55.32,	  49.38,	  40.60,	  





A	  microwave	  vial	  was	  charged	  with	  49a	  (452mg,	  1.03mmol),	  Cs2CO3	  (670mg,	  2.06mmol),	  Pd(dppf)Cl2	  
(75mg,	  0.103mmol)	  and	  DMF	  (3.5ml).	  The	  vial	  was	  evacuated	  and	  backfilled	  with	  nitrogen	  tree	  times.	  
The	  vial	  was	  capped	  properly,	  and	  thereafter	  the	  mixture	  was	  heated	  under	  microwave	   irradiation	  
conditions	  at	  150	  °C	  and	  200	  W	  for	  100	   	  min.	  Afterwards,	  water	  was	  added,	  and	  the	  aq.	   layer	  was	  
extracted	  with	  DCM	  (3x).	  The	  combined	  organic	  fractions	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  
and	  evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  (EtOAc/heptane	  
40:60).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  50a	  (with	  Boc)	  (204mg,	  
0.57mmol,	  55%)	  as	  a	  white	  solid.	  A	  small	  amount	  of	  the	  latter	  was	  deprotected	  by	  using	  TFA	  in	  DCM,	  
in	   order	   to	   get	   more	   comprehensible	   NMR	   spectra.	   LC-­‐MS	   values	   of	   both	   the	   protected	   and	  
deprotected	  version	  are	  reported.	  
¹H-­‐NMR	  (without	  Boc)	  (500	  MHz,	  CDCl3):	  δ	  ,	  7.21	  -­‐	  7.18	  (m,	  2H),	  7.01	  (s,	  1H),	  6.88	  -­‐	  6.86	  (m,	  2H),	  5.64	  
(d,	  J=1.1	  Hz,	  1H),	  5.22	  (s,	  2H),	  4.87	  (d,	  J=1.2	  Hz,	  1H),	  3.86	  (s,	  2H),	  3.79	  (s,	  3H),	  3.62	  (t,	  J=1.0	  2H),	  1.70	  
(s,	  1H);	  13C	  NMR	  (without	  Boc)	  (125	  MHz,	  CDCl3):	  δ	  159.50,	  146.13,	  136.25,	  129.40,	  128.40,	  124.38,	  
117.71,	  114.20,	  104.96,	  55.72,	  55.31,	  51.15,	  42.13;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  356.2097	  	  [M+H]+	  





A	  microwave	  vial	  was	  charged	  with	  49b	  (335mg,	  0.88mmol),	  Cs2CO3	  (576mg,	  1.76mmol),	  Pd(dppf)Cl2	  
(65mg,	  0.088mmol)	  and	  DMF	  (3ml).	  The	  vial	  was	  evacuated	  and	  backfilled	  with	  nitrogen	  tree	  times.	  
The	  vial	  was	  capped	  properly,	  and	  thereafter	  the	  mixture	  was	  heated	  under	  microwave	   irradiation	  
conditions	  at	   150	   °C	  and	  200	  W	   for	  100	  min.	  Afterwards,	  water	  was	  added	  and	   the	  aq.	   layer	  was	  
extracted	  with	  DCM	  (3x).	  The	  combined	  organic	  fractions	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  
and	  evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  (MeOH/DCM	  3:97).	  
The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  50b	  (180mg,	  0.60mmol,	  68%)	  
as	  a	  colourless	  oil.	  Compound	  50b	  was	  isolated	  as	  a	  mixture	  1:0.45	  of	  two	  rotamers.	  
¹H-­‐NMR	   (500	  MHz,	  CDCl3):	  δ	  7.23	  -­‐	  7.16	  (m,	  2.9H)**,	  7.10	  (s,	  1H),	  7.09	  (s,	  0.45H)*,	   	  6.90	  -­‐	  6.85	  (m,	  
2.9H)**,	  5.73	  (s,	  0.45H)*,	  5.72	  (s,	  1H),	  5.23	  (s,	  0.45H)*,	  5.21	  (s,	  1H),	  5.09	  (br,	  0.45H)*,	  4.99	  (br,	  1H),	  
4.65	  (s,	  2H),	  4.49	  (s,	  0.9H)*,	  br	  (4.41,	  0.9H)*,	  3.80	  (s,	  1.35H)*,	  3.79	  (s,	  3H),	  	  2.15	  (s,	  3H),	  2.11	  (s,	  1.35H)*;	  
13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  169.59,	  169.22,	  159.63,	  159.58,	  146.01,	  145.39,	  133.02,	  132.61,	  129.50,	  
129.40,	   128.02,	   125.34,	   124.64,	   115.38,	   114.26,	   107.76,	   106.69,	   55.93,	   55.90,	   55.31,	   53.44,	   51.22,	  
S37	  
	  
45.91,	  42.92,	  38.70,	  21.87,	  21.30;	  broadening	  of	  peaks	  is	  due	  to	  the	  slow	  rotation	  of	  the	  amide	  linkage;	  
LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  298.1546	  [M+H]+,	  Rt	  =	  2.7	  min.	  
	  




A	  MW	  vial	  was	  charged	  with	  49c	  (361mg,	  0.87mmol),	  Cs2CO3	  (565mg,	  1.74mmol),	  Pd(dppf)Cl2	  (64mg,	  
0.087mmol)	  and	  DMF	  (3.5ml).	  The	  vial	  was	  evacuated	  and	  backfilled	  with	  nitrogen	  tree	  times.	  The	  vial	  
was	  capped	  properly,	  and	  thereafter	  the	  mixture	  was	  heated	  under	  microwave	  irradiation	  conditions	  
at	  150	  °C	  and	  200	  W	  for	  100	  min.	  Afterwards,	  water	  was	  added	  and	  extraction	  was	  carried	  out	  by	  using	  
DCM	  (3x).	  The	  combined	  organic	  fractions	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  
in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  column	  chromatography	  (EtOAc/Heptane	  50:50).	  The	  desired	  
fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  50c’	  and	  50c’’	  (180mg,	  0.53mmol,	  61%)	  as	  
white	  solids.	  50c’	  and	  50c’’	  were	  individually	  isolated	  in	  a	  3.5:6.5	  ratio.	  
50c’:	  ¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.18	  -­‐	  7.16	  (m,	  2H),	  7.02	  (s,	  1H),	  6.87	  -­‐	  6.85	  (m,	  2H),	  6.37	  (q,	  J=1.4	  
Hz,	  1H),	  5.17	  (s,	  2H),	  4.70	  (s,	  2H),	  3.77	  (s,	  3H),	  2.81	  (s,	  3H),	  2.04	  (d,	  J=1.4	  Hz,	  3H);	  13C	  NMR	  (125	  MHz,	  
CDCl3):	  δ	  159.56,	  145.93,	  129.35,	  128.22,	  124.52,	  122.00,	  114.24,	  113.97,	  109.68,	  55.62,	  55.30,	  42.21,	  
37.50,	  14.36;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  334.1224	  [M+H]+,	  Rt	  =	  3.1	  min.	  
50c’’:	  ¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.20-­‐7.17	  (m,	  2H),	  7.12	  (s,	  1H),	  6.89-­‐6.86	  (m,	  2H),	  5.82	  (q,	  J=0.8	  Hz,	  
1H),	  5.22	  (s,	  2H),	  5.09	  (q,	  J=0.7	  Hz,	  1H),	  4.51	  (s,	  2H),	  4.23	  (t,	  J=1.0	  Hz,	  2H),	  3.80	  (s,	  3H),	  2.65	  (s,	  3H);	  13C	  
NMR	   (125	  MHz,	  CDCl3):	  δ	  159.70,	  144.94,	  131.62,	  129.49,	  127.72,	  125.19,	  114.33,	  113.29,	  108.54,	  
56.04,	  55.33,	  50.19,	  42.58,	  38.59;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  334.1231	  [M+H]+,	  Rt	  =	  3.3	  min.	  
	  
	  7-­‐methyl-­‐4,5,6,7-­‐tetrahydro-­‐2H-­‐pyrazolo[4,3-­‐c]pyridine	  (12a)	  
	  
A	  0.05	  M	  solution	  of	  50a	   (204mg,	  0.57mmol)	   in	  EtOH	  (11.5ml)	  was	  hydrogenated	  in	  an	  H-­‐cubePro.	  
Initially,	  the	  parameters	  (temperature:	  50°C,	  pressure:	  50bar,	  and	  flowrate:	  0.5ml/min)	  were	  selected	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo,	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (7.3ml)	   and	   anisole	   (0.52ml,	   3.42mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  
the	  volatiles	  were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  
S38	  
	  
The	  latter	  sample	  was	  filtered	  and	  injected	  in	  an	  AutoPurification	  HPLC/MS	  system	  and	  purified	  under	  
basic	  conditions.	  The	  desired	  fractions	  were	  evaporated	  to	  provide	  12a	  (37mg,	  0.27mmol,	  47%)	  as	  a	  
white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.50	  (s,	  1H),	  4.20	  (d,	  J=14.6	  Hz,	  1H),	  4.12	  (d,	  J=14.6	  Hz,	  1H),	  3.54	  (dd,	  
J=5.6,	  12.4	  Hz,	  1H),	  3.25	  -­‐	  3.17	  (m,	  1H),	  2.92	  (dd,	  J=9.6,	  12.4	  Hz,	  1H),	  1.36	  (d,	  J=6.9	  Hz,	  3H);	  13C	  NMR	  
(125	  MHz,	  MeOD4):	  δ	  148.01,	  131.27,	  110.04,	  50.22,	  41.90,	  28.29,	  17.33;	  broadening	  of	  peaks	  is	  due	  




A	   0.05	  M	   solution	   of	   50b	   (180mg,	   0.60mmol)	   in	   EtOH	   (12ml)	   was	   hydrogenated	   in	   a	   H-­‐cubePro.	  
Initially,	  the	  parameters	  (temperature:	  50°C,	  pressure:	  50bar,	  and	  flowrate:	  0.5ml/min)	  were	  selected	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	  vacuo,	  the	  solid	  residue	  was	  dissolved	  in	  TFA	  (5.5ml)	  and	  anisole	  (0.4ml)	  was	  subsequently	  added	  
to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  the	  volatiles	  were	  
removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/	  3:1:1.	  The	  latter	  sample	  was	  
filtered	  and	  injected	  in	  an	  AutoPurification	  HPLC/MS	  system	  and	  purified	  under	  basic	  conditions.	  The	  
desired	  fractions	  were	  evaporated	  to	  provide	  12b	  (60mg,	  0.33mmol,	  55%)	  as	  a	  white	  solid.	  Compound	  
12b	  was	  isolated	  as	  a	  mixture	  1:0.8	  of	  two	  rotamers.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  9.94	  (br,	  1.8H)**,	  7.34	  (s,	  0.8H)*,	  7.31	  (s,	  1H),	  4.81	  (d,	  J=15.7	  Hz,	  1H),	  4.55	  
(d,	  J=15.0	  Hz,	  0.8H)*,	  4.45-­‐4.42	  (m,	  1.8H)**,	  4.26	  (dd,	  J=4.8,	  12.7	  Hz,	  0.8H)*,	  3.77	  (dd,	  J=4.8,	  13.8	  Hz,	  
1H),	  3.27	  (dd,	  J=7.8,	  13.8	  Hz,	  1H),	  3.11	  (dd,	  J=8.4,	  12.7	  Hz,	  0.8H)*,	  3.08	  -­‐	  2.97	  (m,	  1.8H)*,	  2.18	  (s,	  3H),	  
2.16	  (s,	  2.4H)*,	  1.30	  (d,	  J=6.9	  Hz,	  3H),	  1.26	  (d,	  J=6.9	  Hz,	  2.4H)*;	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  170.07,	  
169.97,	  147.58,	  147.52,	  128.95,	  127.84,	  111.76,	  11.26,	  51.14,	  46.37,	  42.97,	  38.81,	  29.55,	  28.53,	  21.99,	  




A	   0.05	  M	   solution	   of	  50c	   (180mg,	   0.53mmol)	   in	   EtOH	   (11ml)	  was	   hydrogenated	   in	   an	  H-­‐cubePro.	  
Initially,	  the	  parameters	  (temperature:	  50°C,	  pressure:	  50bar,	  and	  flowrate:	  0.5ml/min)	  were	  selected	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
S39	  
	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (5.2ml)	   and	   anisole	   (0.37ml,	   3.18mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  
the	  volatiles	  were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  
The	  latter	  sample	  was	  filtered	  and	  injected	  in	  an	  AutoPurification	  HPLC/MS	  system	  and	  purified	  under	  
basic	  conditions.	  The	  desired	  fractions	  were	  evaporated	  to	  provide	  12c	  (65mg,	  0.30mmol,	  56%)	  as	  a	  
white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.42	  (s,	  1H),	  4.37	  (d,	  J=14.0	  Hz,	  1H),	  4.26	  (d,	  J=14.0	  Hz,	  1H),	  3.70	  -­‐	  3.64	  
(m,	  1H),	  3.09	  (m,	  2H),	  2.90	  (s,	  3H),	  1.29	  (d,	  J=6.6	  Hz,	  3H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  148.07,	  130.00,	  
112.20,	  51.72,	  43.51,	  35.92,	  30.21,	  17.85;	  HRMS	  (ESI):	  [M+H]+	  calcd.	  for	  C8H13N3O2S:	  216.0801,	  found:	  
216.0810.	  
	  
(1-­‐(4-­‐methoxybenzyl)-­‐3-­‐vinyl-­‐1H-­‐pyrazol-­‐4-­‐yl)	  methanol	  (51)	  
	  
To	  a	  solution	  of	  44	  (163mg,	  0.67mmol)	  in	  MeOH	  (4ml)	  was	  added	  NaBH4	  (9.0mg,	  0.22mmol)	  at	  0	  °C	  
and	  the	  reaction	  was	  stirred	  for	  1	  h.	  Afterwards,	  the	  reaction	  was	  quenched	  with	  a	  saturated	  solution	  
of	  NH4Cl	  followed	  by	  DCM.	  The	  two	  layers	  were	  separated	  and	  the	  aq.	  phase	  was	  extracted	  with	  DCM	  
(2x).	  The	  combined	  organic	  fractions	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  
vacuo	  to	  51	  (156mg,	  0.64	  mmol,	  95%)	  as	  a	  colourless	  oil.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.25	  (s,	  1H),	  7.21-­‐7.18	  (m,	  2H),	  6.88	  -­‐	  6.86	  (m,	  2H),	  6.75	  (dd,	  J=11.4,	  18.0	  
Hz,	  1H),	  5.83	  (dd,	  J=1.5,	  18.0	  Hz,	  1H),	  5.34	  (dd,	  J=1.5,	  11.4	  Hz,	  1H),	  5.17	  (s,	  2H),	  4.60	  (s,	  2H),	  3.80	  (s,	  
3H);	   13C	  NMR	   (125	  MHz,	  CDCl3):	  δ	  159.57,	  147.96,	  129.50,	  129.42,	  128.04,	  127.97,	  119.43,	  116.27,	  




To	   a	   suspension	   of	   51	   (156mg,	   0.64	   mmol)	   	   in	   THF	   (2.7mL)	   	   was	   added	   portionwise	   	   NaH	   (60%	  
dispersion	  in	  mineral	  oil,	  38.2mg,	  0.96mmol)	  	  	  at	  0	  °C	  under	  nitrogen.	  The	  mixture	  was	  stirred	  at	  0	  °C	  
for	   30	  min,	   then	   	   	   3-­‐bromoprop-­‐1-­‐ene	   (0.066ml,	   0.77mmol)	  was	   added	   and	   the	   temperature	  was	  
raised	  up	   to	  50	  °C.	  After	  12	  h,	   the	   reaction	  was	  cooled	   to	  0	   °C,	  diluted	  with	  EtOAc	  and	  water	  was	  
added.	  The	  two	  layers	  were	  separated	  and	  the	  aq.	  phase	  was	  further	  extracted	  with	  EtOAc	  (2x).	  The	  
combined	  organic	  fractions	  were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo.	  The	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crude	   was	   purified	   by	   flash	   column	   chromatography	   eluting	   (EtOAc/Heptane	   30:70).	   The	   desired	  
fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  52	  (172mg,	  0.60mmol,	  94%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.24	  (s,	  1H),	  7.20-­‐7.17	  (m,	  2H),	  6.87-­‐6.84	  (m,	  2H),	  6.73	  (dd,	  J=11.3,	  17.9	  
Hz,	  1H),	  5.96	  -­‐	  5.88	  (m,	  1H),	  5.81	  (dd,	  J=1.5,	  17.9	  Hz,	  1H),	  5.32	  (dd,	  J=1.5,	  11.3	  Hz,	  1H),	  5.27	  (qd,	  J=1.5,	  
17.3	  Hz,	  1H),	  5.19	  -­‐	  5.16	  (m,	  3H),	  4.40	  (s,	  2H),	  3.98	  (td,	  J=1.5,	  5.8	  Hz,	  2H),	  3.78	  (s,	  3H);	  13C	  NMR	  (125	  
MHz,	   CDCl3):	   δ	   159.52,	   148.52,	   134.69,	   130.04,	   129.47,	   128.14,	   128.00,	   117.27,	   116.51,	   116.22,	  




A	  0.01M	  solution	  of	  52	  (172mg,	  0.60mmol)	  in	  DCM	  was	  degassed	  and	  backfilled	  with	  nitrogen	  3	  times.	  
Then,	  Grubbs	   catalyst	   2nd	   generation	   (25.6mg,	   0.03mmol)	  was	   added	   to	   the	   reaction	  mixture	   and	  
temperature	  was	  raised	  up	  to	  40	  °C.	  After	  3h,	  the	  reaction	  was	  cooled	  down	  and	  DCM	  was	  removed	  
in	   vacuo.	   The	   solid	   residue	  was	   purified	   by	   flash	   column	   chromatography	   eluting	   (EtOAc/Heptane	  
40:60).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  53	  (120mg,	  0.47mmol,	  
78%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.18	  -­‐	  7.16	  (m,	  2H),	  7.04	  (d,	  J=0.7	  Hz,	  1H),	  6.88	  -­‐	  6.85	  (m,	  2H),	  6.55	  (ddt,	  
J=0.7,	  2.0,	  11.9	  Hz,	  1H),	  5.77	  (td,	  J=3.6,	  11.9	  Hz,	  1H),	  5.15	  (s,	  2H),	  4.65	  (s,	  2H),	  4.54	  (dd,	  J=2.0,	  3.6	  Hz,	  
2H),	  3.79	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  159.50,	  148.66,	  130.65,	  129.27,	  128.34,	  126.06,	  121.60,	  




A	  0.05	  M	  solution	  of	  53	  (120mg,	  0.47mmol)	  in	  EtOH	  (9.5ml)	  was	  hydrogenated	  in	  H-­‐cube.	  Initially,	  the	  
parameters	  (temperature:	  25°C,	  pressure:	  15bar	  and	  flowrate:	  0.5ml/min)	  were	  selected	  on	  H-­‐cube	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	   vacuo	   and	   the	   solid	   residue	   was	   dissolved	   in	   TFA	   (4.3ml)	   and	   anisole	   (0.3ml,	   2.8mmol)	   was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12h.	  After	  cooling,	  
the	  volatiles	  were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH.	  The	  latter	  sample	  
was	   directly	   injected	   in	   autoprep	   and	   purified	   under	   basic	   conditions.	   The	   desired	   fractions	  were	  
evaporated	  to	  provide	  15	  (32mg,	  0.23mmol,	  49%)	  as	  a	  white	  solid.	  
S41	  
	  
¹H-­‐NMR	  (400	  MHz,	  MeOD4):	  δ	  7.42	  (s,	  1H),	  4.56	  (s,	  2H),	  4.04-­‐3.99	  (m,	  2H),	  2.93-­‐2.88	  (m,	  2H),	  1.87	  -­‐	  
1.80	  (m,	  2H);	  13C	  NMR	  (100	  MHz,	  MeOD4):	  δ	  149.20,	  130.25,	  119.43,	  74.93,	  65.31,	  29.26,	  26.28;	  HRMS	  




To	  a	  solution	  of	  3	  (230mg,	  0.78mmol)	  in	  MeOH	  (7ml)	  was	  added	  NaBH4	  (59mg,	  1.56mmol)	  at	  0	  °C	  and	  
the	  reaction	  was	  stirred	  for	  1h.	  Afterwards,	  the	  reaction	  was	  quenched	  with	  saturated	  solution	  NH4Cl	  
followed	  by	  DCM.	  The	  aq.	  layer	  was	  then	  extracted	  with	  DCM	  (2x).	  The	  combined	  organic	  fractions	  
were	  washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo	  to	  afford	  54	  (223mg,	  0.75	  mmol,	  
96%).	  	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.12	  (s,	  1H),	  7.03	  -­‐	  7.00	  (m,	  2H),	  6.71	  -­‐	  6.68	  (m,	  2H),	  4.93	  (s,	  2H),	  4.27	  (s,	  
2H),	  3.61	  (s,	  3H),	  3.53	  (s,	  1H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  159.60,	  130.10,	  129.62,	  127.41,	  125.60,	  
121.46,	  114.26,	  56.01,	  55.30,	  55.15;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  297.0200	  ([M+H]+,	  79Br),	  299.0206	  




To	  a	  suspension	  of	  54	  (223mg,	  0.75mmol)	  in	  THF	  (4.3mL)	  was	  added	  portionwise	  	  	  NaH	  (60%	  dispersion	  
in	  mineral	   oil,	   44.8mg,	   1.12mmol)	   	   	   at	   0	   °C.	   The	  mixture	  was	   stirred	   at	   0	   °C	   for	   30	  min,	   then	   	   	   3-­‐
bromoprop-­‐1-­‐ene	  (0.081ml,	  0.9mmol)	  was	  added	  and	  the	  temp	  was	  raised	  up	  to	  50	  °C.	  After	  12	  h,	  the	  
reaction	  was	  cooled	  to	  0°	  C	  and	  water	  was	  added	  followed	  by	  EtOAc.	  The	  two	  layers	  were	  separated	  
and	  the	  aq.	  phase	  was	  extracted	  with	  EtOAc	  (3x).	  The	  organics	  were	  washed	  with	  brine,	  dried	  over	  
MgSO4	   and	   evaporated	   in	   vacuo.	   The	   residue	   was	   purified	   by	   flash	   column	   chromatography	  
(EtOAc/Heptane	  25:75)	  to	  afford	  55	  (235mg,	  0.7mmol,	  93%).	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  7.25	  (s,	  1H),	  7.22-­‐7.18	  (m,	  2H),	  6.89	  -­‐	  6.86	  (m,	  2H),	  5.96	  -­‐	  5.86	  (m,	  1H),	  
5.28	  (qd,	  J=1.5,	  17.2	  Hz,	  1H),	  5.19	  (qd,	  J=1.4,	  10.3	  Hz,	  1H),	  5.16	  (s,	  2H),	  4.30	  (s,	  2H),	  3.99	  (td,	  J=1.4,	  5.7	  
Hz,	  2H),	  3.80	  (s,	  3H);	  13C	  NMR	  (100	  MHz,	  CDCl3):	  δ	  159.81,	  134.50,	  130.35,	  129.76,	  127.33,	  126.62,	  
118.62,	  117.49,	  114.34,	  71.17,	  62.46,	  56.30,	  55.36;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  337.0464	  ([M+H]+,	  







A	  microwave	   vial	  was	   charged	  with	  55	   (235mg,	   0.7mmol),	   Cs2CO3	  (456mg,	   1.40mmol),	   Pd(dppf)Cl2	  
(51mg,	  0.07mmol)	  and	  DMF	  (2.5ml).	  The	  vial	  was	  capped	  properly,	  and	  thereafter	  the	  mixture	  was	  
heated	  under	  microwave	  irradiation	  conditions	  at	  150	  °C	  and	  200	  W	  for	  100	  	  min.	  Afterwards,	  water	  
was	   added,	   and	   the	   aq.	   layer	  was	   extracted	  with	  DCM	   (3x).	   The	   combined	  organic	   fractions	  were	  
washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo.	  The	  crude	  was	  purified	  by	  flash	  column	  
chromatography	  (EtOAc/Heptane	  35:65).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  
to	  afford	  56’	  and	  56’’	  (116mg,	  0.45mmol,	  65%)	  as	  white	  solids.	  56’	  and	  56’’	  were	  individually	  isolated	  
in	  a	  4:6	  ratio.	  	  
56’:	  ¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.20	  -­‐	  7.17	  (m,	  2H),	  6.93	  (s,	  1H),	  6.88	  -­‐	  6.86	  (m,	  2H),	  6.33	  (q,	  J=1.5	  Hz,	  
1H),	  5.20	  (s,	  2H),	  5.08	  (s,	  2H),	  3.80	  (s,	  3H),	  1.95	  (d,	  J=1.5	  Hz,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  159.49,	  
145.76,	  141.62,	  129.24,	  128.71,	  123.22,	  114.20,	  110.04,	  107.03,	  63.42,	  55.31,	  55.28;	  LC-­‐MS,	  6	  min	  run,	  
(ESI+)	  m/z	  257.1312	  [M+H]+,	  Rt	  =	  3.1	  min.	  
56’’:	  ¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  7.21	  -­‐	  7.16	  (m,	  2H),	  7.03	  (s,	  1H),	  6.87	  -­‐	  6.84	  (m,	  2H),	  5.69	  (q,	  J=1.0	  
Hz,	  1H),	  5.22	  (s,	  2H),	  4.91	  (q,	  J=1.0	  Hz,	  1H),	  4.67	  (s,	  2H),	  4.35	  (t,	  J=1.4	  Hz,	  2H),	  3.77	  (s,	  3H);	  13C	  NMR	  
(126	  MHz,	  CDCl3):	  δ	  159.52,	  144.62,	  134.51,	  129.37,	  128.25,	  123.96,	  116.31,	  114.21,	  105.29,	  70.58,	  




A	  0.05	  M	  solution	  56	  (116mg,	  0.45mmol)	  in	  EtOH	  (9ml)	  was	  hydrogenated	  in	  an	  H-­‐cubePro.	  Initially,	  
the	  parameters	  (temperature:	  50°C,	  pressure:	  50bar,	  and	  flowrate:	  0.5ml/min)	  were	  selected	  and	  a	  
10%	  Pd/C	  CatCart	  was	  fitted	  in	  the	  instrument.	  After	  pumping	  pure	  EtOH	  for	  10	  min,	  the	  injection	  line	  
was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  process	  was	  
started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  in	  vacuo	  
and	  the	  solid	  residue	  was	  dissolved	  in	  TFA	  (4.1ml)	  and	  anisole	  (0.29ml,	  2.70mmol)	  was	  subsequently	  
added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  the	  volatiles	  
were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  
sample	  was	   filtered	   and	   injected	   in	   an	  AutoPurification	  HPLC/MS	   system	  and	  purified	  under	  basic	  
conditions.	  The	  desired	  fractions	  were	  evaporated	  to	  provide	  14	  (32mg,	  0.23mmol,	  51%)	  as	  a	  white	  
solid.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.32	  (s,	  1H),	  4.70	  (d,	  J=13.3	  Hz,	  1H),	  4.66	  (d,	  J=13.3	  Hz,	  1H),	  3.97	  (dd,	  
J=5.0,	  11.2	  Hz,	  1H),	  3.45	  (dd,	  J=6.9,	  11.2	  Hz,	  1H),	  3.02	  -­‐	  2.95	  (m,	  1H),	  1.24	  (d,	  J=6.9	  Hz,	  3H);	  13C	  NMR	  
S43	  
	  
(125	  MHz,	  MeOD4):	  δ	  135.46,	  124.05,	  114.21,	  72.71,	  64.69,	  30.59,	  16.82;	  broadening	  of	  peaks	  is	  due	  
to	  tautomerism;	  HRMS	  (ESI):	  [M+H]+	  calcd.	  for	  C7H10N2O:	  139.0865,	  found:	  139.0866.	  
	  
4-­‐formyl-­‐1-­‐(4-­‐methoxybenzyl)-­‐1H-­‐pyrazole-­‐3-­‐carboxylic	  acid	  (57)	  
	  
To	   a	   microwave	   vial	   were	   added	   3b	   945mg,	   3.18mmol),	   1,1,3-­‐trioxo-­‐1,2-­‐benzothiazole-­‐2-­‐
carbaldehyde	   (815mg,	  3.81mmol),	  KF	   (560mg,	  9.54mmol),	  Xantphos	   (558mg,	  0.95mmol),	  Pd(OAc)2	  
(3.8036mg,	  0.318mmol)	  .	  Then,	  the	  microwave	  vial	  was	  capped,	  evacuated	  and	  backfilled	  three	  times	  
with	  nitrogen.	  Afterwards,	  DMF	  (17mL)	  was	  added	  and	  the	  final	  mixture	  was	  stirred	  at	  90	  °C	  for	  48h.	  
Thereafter,	  water	  (0.087ml,	  4.17mmol)	  and	  Et3N	  (1.12ml,	  7.95mmol)	  were	  added	  and	  the	  mixture	  was	  
stirred	  for	  30	  more	  min	  at	  rt.	  The	  latter	  was	  finally	  filtered	  and	  DMF	  removed.	  The	  crude	  was	  then	  
injected	   in	   an	  AutoPurification	  HPLC/MS	   system	   and	   purified	   under	   acidic	   conditions	   to	   afford	  57	  
(400mg,	  1.53mmol,	  48%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  9.94	  (s,	  1H),	  7.92	  (s,	  1H),	  7.28	  -­‐	  7.25	  (m,	  2H),	  6.92-­‐6.89	  (m,	  2H),	  5.35	  (s,	  
2H),	  3.81	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  186.48,	  160.38,	  135.87,	  130.34,	  125.15,	  122.88,	  114.78,	  
57.14,	  55.39;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  261.0889	  [M+H]+,	  Rt	  =	  3.0	  min.	  
	  
4-­‐(hydroxymethyl)-­‐1-­‐(4-­‐methoxybenzyl)-­‐1H-­‐pyrazole-­‐3-­‐carboxylic	  acid	  (58)	  
	  
To	  a	  mixture	  of	  57	  (215mg,	  0.82mmol)	  in	  Methanol	  (4.5mL)	  at	  0	  °C,	  NaBH4	  (19.3mg,	  0.57mmol)	  	  	  	  was	  
added	  and	  the	  reaction	  stirred	  for	  30	  min.	  Then,	  volatiles	  were	  removed	  under	  reduced	  pressure,	  a	  
saturated	   solution	   of	   NH4Cl	   was	   added	   and	   extraction	   was	   carried	   out	   with	   DCM	   (3	   times).	   	   The	  
organics	  were	  then	  washed	  with	  brine	  and	  dried	  over	  MgSO4	  before	  concentration	  to	  dryness.	  The	  
crude	  was	  then	  injected	  in	  an	  AutoPurification	  HPLC/MS	  system	  and	  purified	  under	  acidic	  conditions	  
to	  afford	  58	  (180mg,	  0.68mmol,	  83%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.62	  (s,	  1H),	  7.26	  -­‐	  7.24	  (m,	  2H),	  6.90	  -­‐	  6.88	  (m,	  2H),	  5.27	  (s,	  2H),	  4.71	  
(s,	  2H),	  3.76	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  165.78,	  161.29,	  141.22,	  131.43,	  130.63,	  1299.46,	  






To	  a	  solution	  of	  	  58	  (180mg,	  0.68mmol)	  in	  DMF	  (7mL),	  HATU	  (113.3mg,	  0.75mmol)	  and	  DIPEA	  (0.36ml,	  
2.04mmol)	  	  were	  added	  and	  the	  final	  mixture	  was	  stirred	  at	  rt	  for	  2	  h.	  Then,	  water	  was	  added	  and	  the	  
mixture	  extracted	  with	  DCM	  (3x).	   	  The	  organics	  were	  washed	  with	  brine,	  separated	  and	  dried	  over	  
MgSO4	  before	  concentration	  to	  dryness.	  The	  crude	  was	  then	  purified	  by	  flash	  column	  chromatography	  
(EtOAc/Heptane	  35:65).	   The	  desired	   fractions	  were	   concentrated	   to	  dryness	   in	   vacuo	   to	  afford	  59	  
(115mg,	  0.46mmol,	  68%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  7.31	  (t,	  J=0.9	  Hz,	  1H),	  7.28	  -­‐	  7.25	  (m,	  2H),	  6.91	  -­‐	  6.88	  (m,	  2H),	  5.37	  (s,	  2H),	  
5.19	   (d,	   J=0.9	  Hz,	   2H),	   3.80	   (s,	   3H);	   13C	  NMR	   (125	  MHz,	   CDCl3):	   δ	   163.54,	   159.96,	   144.66,	   131.76,	  
129.75,	  126.99,	  123.13,	  114.45,	  65.30,	  57.30,	  55.36;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  245.1199	  [M+H]+,	  




59	  (115mg,	  0.46mmol)	  was	  dissolved	  in	  TFA	  (4.3ml)	  and	  anisole	  (0.30ml,	  2.76mmol)	  was	  subsequently	  
added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  2	  h.	  After	  cooling,	  the	  volatiles	  
were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/MeCN/water	  3:1:1.	  The	  latter	  
sample	  was	   filtered	   and	   injected	   in	   an	  AutoPurification	  HPLC/MS	   system	  and	  purified	  under	  basic	  
conditions.	  The	  desired	  fractions	  were	  evaporated	  to	  provide	  16	  (24mg,	  0.19	  mmol,	  41%)	  as	  a	  white	  
solid.	  
¹H-­‐NMR	  (400	  MHz,	  DMSO-­‐d6):	  δ	  13.82	  (br,	  1H),	  7.89	  (s,	  1H),	  5.30	  (s,	  2H);	  13C	  NMR	  (125	  MHz,	  DMSO-­‐
d6):	  δ	  164.27,	  144.04,	  132.28,	  124.67,	  66.21;	  HRMS	  (ESI):	  [M+H]+	  calcd.	  for	  C5H4N2O2:	  125.0346,	  found:	  
125.0356.	  
	  




To	  a	  mixture	  of	  	  	  57	  (175mg,	  0.67mmol)	  and	  MgSO4	  (384mg,	  3.35mmol)	  in	  DCM	  (4mL)	  was	  added	  	  	  (2,4-­‐
dimethoxyphenyl)methanamine	  (0.11ml,	  0.81mmol).	  The	  mixture	  was	  stirred	  at	  rt	  for	  24	  h.	  Then,	  the	  
latter	  was	  filtered	  and	  volatiles	  were	  removed	  in	  vacuo.	  The	  crude	  was	  solubilized	  in	  MeOH	  (8mL)	  and	  
NaBH4	   (24mg,	  0.67mmol)	  was	  added.	  The	   reaction	  was	   stirred	  at	  25	   oC	   for	  3	  h.	   Subsequently,	   the	  
mixture	  was	  quenched	  by	  adding	  NaHCO3	  and	  extraction	  was	  carried	  out	  with	  DCM	  (3x).	  The	  organics	  
were	   washed	   with	   brine	   and	   dried	   over	   MgSO4	   before	   concentration	   to	   dryness.	   The	   crude	   was	  
purified	  by	  flash	  chromatography	  (EtOAc/Heptane	  40:60).	  The	  desired	  fractions	  were	  concentrated	  to	  
dryness	  in	  vacuo	  to	  afford	  60	  (256mg,	  0.62mmol,	  92%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  10.81	  (br,	  1H),	  7.32	  (br,	  1H),	  7.10	  -­‐	  7.05	  (m,	  4H),	  6.80	  (d,	  J=8.5	  Hz,	  2H),	  
6.33	  (s,	  2H),	  5.01	  (s,	  2H),	  4.01	  (s,	  2H),	  3.87	  (s,	  2H),	  3.76	  (s,	  3H),	  3.71	  (s,	  3H),	  3.68	  (s,	  3H);	  13C	  NMR	  (100	  
MHz,	   CDCl3):	   δ	   167.88,	   161.63,	   159.45,	   159.02,	   147.62,	   132.52,	   130.18,	   129.52,	   127.91,	   114.11,	  
113.65,	   112.92,	   104.28,	   98.13,	   55.46,	   55.33,	   55.26,	   44.08,	   41.02;	   LC-­‐MS,	   6	   min	   run,	   (ESI+)	   m/z	  




To	  a	  solution	  of	  60	  (256mg,	  0.62mmol)	  in	  DMF	  (5mL),	  HATU	  (255mg,	  0.68mmol)	  and	  DIPEA	  (0.317ml,	  
1.86mmol)	  	  were	  added	  and	  the	  final	  mixture	  was	  stirred	  at	  rt	  for	  2	  h.	  Then,	  water	  was	  added	  and	  the	  
mixture	  extracted	  with	  DCM	  (3x).	   	  The	  organics	  were	  washed	  with	  brine,	  separated	  and	  dried	  over	  
MgSO4	  before	  concentration	  to	  dryness.	  The	  crude	  was	  then	  purified	  by	  flash	  column	  chromatography	  
(EtOAc/Heptane	  60:40).	   	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	   in	  vacuo	  to	  afford	  61	  
(200mg,	  0.51mmol,	  82%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.30	  (s,	  1H),	  7.29-­‐7.26	  (m,	  2H),	  7.08	  (d,	  J=8.2	  Hz,	  1H),	  6.81	  -­‐	  6.78	  (m,	  
2H),	  6.49	  (d,	  J=2.3	  Hz,	  1H),	  6.42	  (dd,	  J=2.3,	  8.2	  Hz,	  1H),	  5.33	  (s,	  2H),	  4.55	  (s,	  2H),	  4.03	  (s,	  2H),	  3.75	  (s,	  
3H),	  3.72	  (s,	  3H),	  3.68	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  162.54,	  161.08,	  160.67,	  160.04,	  140.59,	  
132.90,	   131.88,	   130.73,	   130.69,	   130.13,	   118.31,	   115.09,	   105.74,	   99.55,	   56.01,	   55.90,55.78,	   54.25,	  




61	  (200mg,	  0.51mmol)	  was	  dissolved	  in	  TFA	  (4.5ml)	  and	  anisole	  (0.33ml,	  3.06mmol)	  was	  subsequently	  
added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  2	  h.	  After	  cooling,	  the	  volatiles	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were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  The	  latter	  
sample	  was	   filtered	   and	   injected	   in	   an	  AutoPurification	  HPLC/MS	   system	  and	  purified	  under	  basic	  
conditions.	  The	  desired	  fractions	  were	  evaporated	  to	  provide	  17	   (25mg,	  0.2mmol,	  40%)	  as	  a	  white	  
solid.	  
¹H-­‐NMR	  (500	  MHz,	  DMSO-­‐d6):	  δ	  13.30	  (br,	  1H),	  8.25	  (br,	  1H),	  7.70	  (br,	  1H),	  4.16	  (d,	  2H);	  13C	  NMR	  (125	  
MHz,	   DMSO-­‐d6):	   δ	   165.19,	   150.83,	   126.35,	   123.12,	   40.10;	  HRMS	   (ESI):	   [M+H]+	   calcd.	   for	   C5H5N3O:	  
124.0506,	  found:	  124.0515.	  
	  
methyl	  4-­‐formyl-­‐1-­‐(4-­‐methoxybenzyl)-­‐1H-­‐pyrazole-­‐3-­‐carboxylate	  (62)	  
	  
To	  a	  microwave	  vial	  were	  added	  3b	  (770mg,	  2.6mmol),	  1,1,3-­‐trioxo-­‐1,2-­‐benzothiazole-­‐2-­‐carbaldehyde	  
(660mg,	   3.12mmol),	   KF	   (455mg,	   7.8mmol),	   Xantphos	   (452mg,	   0.0508mmol),	   Pd(OAc)2	   (58.5mg,	  
0.26mmol).	  Then,	  the	  microwave	  vial	  was	  capped,	  evacuated	  and	  backfilled	  three	  times	  with	  nitrogen.	  
Afterwards,	  DMF	  (14mL)	  was	  added	  and	  the	  final	  mixture	  was	  stirred	  at	  90	  °C	  for	  48	  h.	  Thereafter,	  
MeOH	  (0.16ml,	  3.9mmol)	  and	  Et3N	  (0.9ml,	  7.8mmol)	  were	  added	  and	  the	  mixture	  was	  stirred	  for	  30	  
more	  min	  at	  rt.	  The	  latter	  was	  finally	  filtered	  and	  DMF	  removed	  in	  vacuo.	  The	  crude	  was	  then	  purified	  
by	  flash	  column	  chromatography	  (EtOAc/Heptane	  40:60).	  The	  desired	  fractions	  were	  concentrated	  to	  
dryness	  in	  vacuo	  to	  afford	  62	  (358mg,	  1.3mmol,	  50%)	  as	  a	  pale	  yellow	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  10.31	  (s,	  1H),	  7.83	  (s,	  1H),	  7.22-­‐7.19	  (m,	  2H),	  6.88	  -­‐	  6.85	  (m,	  2H),	  5.28	  (s,	  
2H),	  3.96	  (s,	  3H),	  3.77	  -­‐	  3.76	  (m,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  186.29,	  161.84,	  160.20,	  142.95,	  
132.15,	  130.07,	  129.83,	  125.69,	  125.02,	  114.63,	  114.38,	  56.90,	  55.32,	  52.48;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  
m/z	  275.1021	  [M+H]+,	  Rt	  =	  3.5	  min.	  
	  
methyl	  (E)-­‐4-­‐(((tert-­‐butylsulfinyl)imino)methyl)-­‐1-­‐(4-­‐methoxybenzyl)-­‐1H-­‐pyrazole-­‐3-­‐carboxylate	  (63)	  
	  
A	  solution	  of	  62	  (358mg,	  1.3mmol)	  and	  Ti(OEt)4	  (1.36ml,	  6.5mmol)	  	  in	  DCM	  (4.3mL)	  	  was	  stirred	  at	  25	  
oC	   	   for	  5	  min.	  Then,	  2-­‐methylpropane-­‐2-­‐sulfinamide	  (173.5mg,	  1.43mmol)	  was	  added	  and	  the	  final	  
mixture	  was	  stirred	  at	  25	  oC	  for	  3	  h.	  	  Thereafter,	  water	  was	  added	  and	  the	  following	  suspension	  was	  
filtered	  through	  celite,	  eluting	  with	  DCM.	  Solvent	  was	  removed	   in	  vacuo	  and	  the	  crude	  purified	  by	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flash	  column	  chromatography	   (EtOAc/Heptane	  50:50).	   The	  desired	   fractions	  were	  concentrated	   to	  
dryness	  in	  vacuo	  to	  afford	  63	  (462mg,	  1.2mmol,	  92%)	  as	  a	  yellow	  oil.	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  9.00	  (s,	  1H),	  7.86	  (s,	  1H),	  7.28-­‐7.24	  (m,	  2H),	  6.92-­‐6.88	  (m,	  2H),	  5.35	  (d,	  
J=14.6	  Hz,	  1H),	  5.30	  (d,	  J=14.6	  Hz,	  1H),	  3.98	  (s,	  3H),	  3.81	  (s,	  3H),	  1.20	  (s,	  9H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  
δ	  161.92,	  160.05,	  155.87,	  141.86,	  130.81,	  129.90,	  126.22,	  121.31,	  114.54,	  57.55	  56.92,	  55.35,	  52.47,	  
22.60;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  378.1466	  [M+H]+,	  Rt	  =	  4.0	  min.	  
	  
methyl	   4-­‐(1-­‐((tert-­‐butylsulfinyl)amino)-­‐2-­‐nitroethyl)-­‐1-­‐(4-­‐methoxybenzyl)-­‐1H-­‐pyrazole-­‐3-­‐carboxylate	  
(64)	  
	  
TBAF	   (1M	   solution	   in	   THF,	   1.22ml,	   1.2mmol)	  was	   added	   to	   a	   solution	   of	  63	   (462mg,	   1.2mmol)	   in	  
nitrometane/dioxane	  (4:1)	  (5.2ml).	  The	  final	  solution	  was	  stirred	  at	  rt	  for	  30	  min.	  Then,	  volatiles	  were	  
removed	  under	  reduced	  pressure,	  water	  was	  added	  and	  extraction	  was	  carried	  out	  with	  DCM.	  	  The	  
organics	  were	  washed	  with	  brine,	  separated	  and	  dried	  over	  MgSO4	  before	  concentration	  to	  dryness.	  
The	   crude	   was	   then	   purified	   by	   flash	   column	   chromatography	   (MeOH/DCM	   3:97).	   The	   desired	  
fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  provide	  64’	  (RsR/SsS)	  and	  64’’	  (RsS/SsR)	  (445mg,	  
1.1mmol,	  90%)	  as	  pale	  yellow	  solids.	  64’	  and	  64’’	  were	  individually	  isolated	  in	  a	  2:8	  ratio.	  	  
64’:	  ¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.31	  (s,	  1H),	  7.17-­‐7.14	  (m,	  2H),	  6.90	  -­‐	  6.87	  (m,	  2H),	  5.32	  -­‐	  5.23	  (m,	  
4H),	  5.06	  (dd,	  J=5.6,	  12.9	  Hz,	  1H),	  4.84	  (dd,	  J=7.5,	  13.0	  Hz,	  1H),	  3.97	  (s,	  3H),	  3.80	  (s,	  3H),	  1.17	  (s,	  9H);	  
13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  163.67,	  159.97,	  138.99,	  129.62,	  126.41,	  122.35,	  114.51,	  56.70,	  56.50,	  
55.32,	  52.59,	  50.62,	  22.55;	  LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  439.1662	  [M+H]+,	  Rt	  =	  3.6	  min.	  	  
64’’:	  ¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.38	  (s,	  1H),	  7.19-­‐7.16	  (m,	  2H),	  6.89-­‐7.86	  (m,	  2H),	  5.32	  (d,	  J=10.5	  Hz,	  
1H),	  5.27	  (d,	  J=14.8	  Hz,	  1H),	  5.23	  (d,	  J=14.8	  Hz,	  1H),	  5.19-­‐5.14	  (m,	  1H),	  4.80	  (dd,	  J=9.5,	  12.5	  Hz,	  1H),	  
4.48	  (dd,	  J=5.1,	  12.6	  Hz,	  1H),	  3.96	  (s,	  3H),	  3.79	  (s,	  3H),	  1.15	  (s,	  9H);	  13C	  NMR	  (125	  MHz,	  DMSO-­‐d6):	  δ	  
164.14,	   159.99,	   139.09,	   130.07,	   129.81,	   126.27,	   122.80,	   114.55,	   78.92,	   56.74,	   55.31,	   52.63,	   51.51,	  







Separately,	  both	  diastereomeric	  pairs	  of	  enantiomers	  64’	  and	  64’’	  (445mg,	  1.1mmol)	  were	  dissolved	  
in	  EtOH	  (11ml),	  Zn	  (1.33g,	  22.0mmol)	  was	  subsequently	  added	  and	  the	  temperature	  raised	  up	  to	  80	  
°C.	  Then,	  AcOH	  (11ml)	  was	  added	  and	  the	  final	  mixture	  was	  stirred	  at	  80	  °C	  for	  30	  min.	  Thereafter,	  the	  
latter	  was	  filtered	  and	  solvents	  were	  removed	  under	  vacuum.	  To	  the	  crude	  was	  then	  added	  dioxane	  
(10ml)	  and	  Et3N	  (0.7ml,	  5.5mmol),	  and	  the	  solution	  was	  stirred	  at	  rt.	  for	  12	  h.	  The	  solution	  was	  then	  
diluted	  with	  DCM,	  followed	  by	  a	  saturated	  solution	  of	  NH4Cl.	  The	  two	  layers	  were	  then	  separated	  and	  
the	  aq.	  one	  was	  further	  extracted	  with	  DCM	  (2x).	  The	  combined	  organics	  were	  washed	  with	  brine	  and	  
dried	   over	  MgSO4	   before	   concentration	   to	   dryness.	   The	   crude	  was	   then	   purified	   by	   flash	   column	  
chromatography	  (MeOH/DCM	  5:95).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  
afford	  65’	  (RsR/SsS)	  and	  65’’	  (RsS/SsR)	  (326mg,	  0.86	  mmol,	  85%)	  as	  white	  solids.	  	  
65’:	  ¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.78	  (s,	  1H),	  7.71	  (d,	  J=8.4	  Hz,	  2H),	  7.64	  (s,	  1H),	  7.32	  (d,	  J=8.4	  Hz,	  2H),	  
5.78	  (d,	  J=14.6	  Hz,	  1H),	  5.68	  (d,	  J=14.6	  Hz,	  1H),	  5.56	  (d,	  J=8.7	  Hz,	  1H),	  4.97	  -­‐	  4.91	  (m,	  1H),	  4.25	  -­‐	  4.22	  
(m,	  5H),	  1.65	  (s,	  9H);	  13C	  NMR	  (125	  MHz,	  DMSO-­‐d6):	  δ	  162.52,	  159.72,	  141.98,	  129.84,	  128.78,	  127.47,	  
126.63,	   121.66,	   114.28,	   56.47,	   56.35,	   55.29,	   48.91,	   47.62,	   22.72;	   LC-­‐MS,	   6	   min	   run,	   (ESI+)	   m/z	  
377.1652	  [M+H]+,	  Rt	  =	  3.0	  min.	  
65’’:	  ¹H-­‐NMR	  (500	  MHz,	  DMSO):	  δ	  7.80	  (s,	  1H),	  7.59	  (t,	  J=2.7	  Hz,	  1H),	  7.29-­‐7.26	  (m,	  2H),	  6.93-­‐6.91	  (m,	  
2H),	  5.65	  (d,	  J=7.8	  Hz,	  1H),	  5.30	  (s,	  2H),	  4.54	  -­‐	  4.49	  (m,	  1H),	  3.34	  (td,	  J=2.7,	  5.4	  Hz,	  2H),	  3.32	  (s,	  3H),	  
1.12	  (s,	  9H);	  13C	  NMR	  (125	  MHz,	  DMSO-­‐d6):	  δ	  161.55,	  159.48,	  142.00,	  130.08,	  129.24,	  128.74,	  124.03,	  





65’	  and	  65’’	   (325mg,	  0.86mmol)	  were	  dissolved	   in	  TFA	  (11ml)	  and	  anisole	  (0.77ml,	  5.16mmol)	  was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80°	  C	  for	  12	  h.	  After	  cooling,	  
the	  volatiles	  were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  
The	  latter	  sample	  was	  filtered	  and	  injected	  in	  an	  AutoPurification	  HPLC/MS	  system	  and	  purified	  under	  
basic	  conditions.	  The	  desired	  fractions	  were	  evaporated	  to	  provide	  18	  (80mg,	  0.52	  mmol,	  60%)	  as	  a	  
reddish	  oil.	  
¹H-­‐NMR	  (500	  MHz,	  MeOD4):	  δ	  7.70	  (s,	  1H),	  4.22	  (dd,	  J=5.0,	  6.7	  Hz,	  1H),	  3.63	  (dd,	  J=5.0,	  12.7	  Hz,	  1H),	  
3.37	  (dd,	  J=6.7,	  12.7	  Hz,	  1H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  164.19,	  140.43,	  129.66,	  125.82,	  50.74,	  






A	   flask	   was	   charged	   with	   3b	   (155mg,	   0.52mmol),	   CsF	   (183.5mg,	   1.19mmol),	   Pd(t-­‐Bu3P)2	   (10.7mg,	  
0.021mmol)	   and	   1,4-­‐dioxane	   (2ml)	   under	   nitrogen	   atmosphere.	   Then,	   trimethyl(2-­‐
tributylstannylethynyl)silane	  (0.20ml,	  0.57mmol)	  was	  added	  and	  the	  final	  mixture	  was	  stirred	  at	  rt	  for	  
24h.	  Subsequently,	   the	   reaction	  was	  diluted	  with	  Et2O	  and	  water	  was	  added.	  The	   two	   layers	  were	  
separated	  and	  the	  aq.	  one	  was	  extracted	  further	  with	  Et2O	  (2x).	  The	  combined	  organics	  were	  washed	  
with	  brine	  and	  dried	  over	  MgSO4	  before	   concentration	   to	  dryness.	   The	   crude	  was	  passed	   through	  
celite	  and	  then	  purified	  by	  flash	  column	  chromatography	  eluting	  15%	  EtOAc	  in	  heptane.	  The	  desired	  
fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  66	  (138mg,	  0.44mmol,	  84%)	  as	  a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  9.90	  (s,	  1H),	  7.83	  (s,	  1H),	  7.25-­‐7.22	  (m,	  2H),	  6.91	  -­‐	  6.88	  (m,	  2H),	  5.23	  (s,	  
2H),	  3.80	  (s,	  3H),	  0.29	  (s,	  9H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  184.77,	  160.45,	  138.01,	  130.37,	  126.33,	  





To	  a	  solution	  of	  66	   (138mg,	  0.44mmol)	   in	  DCM	  1.5(ml)	  was	  added	  MgSO4	   (213mg,	  1.76mmol)	  and	  
methylamine	  (2M	  in	  THF,	  0.88ml,	  1.76mmol),	  and	  the	  reaction	  was	  stirred	  at	  rt	   for	  24h.	  Then,	   the	  
mixture	  was	  filtered	  and	  volatiles	  were	  evaporated	  in	  vacuo.	  The	  solid	  residue	  was	  dissolved	  in	  MeOH	  
(3ml)	  and	  NaBH4	  (33.5mg,	  0.88mmol)	  was	  added	  at	  0	  °C.	  The	  reaction	  was	  stirred	  at	  rt	  temperature	  
for	   8h.	   Afterwards,	   a	   3M	  NaOH	   aq.	   solution	  was	   added	   followed	   by	   EtOAc.	   The	   two	   layers	   were	  
separated	  and	   the	  aq.	  phase	  was	  extracted	  with	  EtOAc	   (3x).	  The	  combined	  organic	   fractions	  were	  
washed	  with	  brine,	  dried	  over	  MgSO4	  and	  evaporated	  in	  vacuo.	  The	  crude	  was	  then	  purified	  by	  flash	  
column	   chromatography	   eluting	   (MeOH/DCM	   6:94).	   The	   desired	   fractions	   were	   concentrated	   to	  
dryness	  in	  vacuo	  to	  afford	  67a	  (89.2mg,	  0.35mmol,	  79%)	  as	  a	  reddish	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ,	  7.22	  (s,	  1H),	  7.18	  (d,	  J=8.5	  Hz,	  2H),	  6.84	  (d,	  J=8.5	  Hz,	  2H),	  5.15	  (s,	  2H),	  
3.77	  (s,	  3H),	  3.62	  (s,	  2H),	  3.18	  (s,	  1H),	  2.39	  (s,	  3H),	  1.40	  (br,	  1H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  159.65,	  
132.97,	  129.55,	  128.18,	  127.71,	  124.27,	  114.27,	  80.23,	  75.75,	  56.08,	  55.29,	  45.22,	  35.93;	  LC-­‐MS,	  6	  min	  




tert-­‐butyl	  ((3-­‐ethynyl-­‐1-­‐(4-­‐methoxybenzyl)-­‐1H-­‐pyrazol-­‐4-­‐yl)methyl)(methyl)carbamate	  (67b)	  
	  
A	  solution	  of	  Boc	  anhydride	  (100mg,	  0.45mmol)	  in	  THF	  (0.3ml)	  was	  added	  to	  a	  mixture	  of	  67a	  (89.2mg,	  
0.35mmol)	  and	  Et3N	  (0.06ml,	  0.42mmol)	  in	  THF	  (1.5ml)	  at	  0	  °C.	  Then,	  the	  temperature	  was	  allowed	  to	  
reach	   rt	   and	   the	   reaction	  was	   stirred	   for	   2	   h.	   Afterwards,	  water	  was	   added,	   the	   two	   layers	  were	  
separated	  and	  the	  aq.	  phase	  was	  extracted	  further	  with	  DCM	  (2x).	  The	  combined	  organic	  fractions	  
were	  washed	  with	  brine	  and	  dried	  over	  MgSO4	  before	  concentration	  to	  dryness.	  The	  crude	  was	  then	  
purified	   by	   flash	   column	   chromatography	   (EtOAc/Heptane	   20:80).	   The	   desired	   fractions	   were	  
concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  67b	  (123.8mg,	  0.34mmol,	  96%)	  as	  a	  yellow	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.28	  (s,	  1H),	  7.18	  (d,	  J=8.4	  Hz,	  2H),	  6.86	  (d,	  J=8.4	  Hz,	  2H),	  5.16	  (s,	  2H),	  4.26	  
(s,	  2H),	  3.78	  (s,	  3H),	  3.17	  (s,	  1H),	  2.82	  (s,	  3H),	  1.43	  (s,	  9H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  159.71,	  155.74,	  
129.58,	  129.37,	  127.46,	  122.28,	  114.32,	  80.15,	  79.54,	  75.61,	  56.16,	  55.30,	  42.22,	  34.12,	  28.44;	  LC-­‐MS,	  





67b	   (123.8mg,	  0.34mmol)	  was	  dissolved	   in	  THF	   (1.8ml)	  at	   -­‐78°C,	   followed	  by	  dropwise	  addition	  of	  
nBuLi	  (2.5M	  in	  hexane,	  0.182ml,	  0.41mmol).	  The	  resulted	  solution	  stirred	  at	  -­‐78°C	  for	  30	  min.	  Then,	  
methyl	  chloroformate	  (0.035ml,	  0.44mmol)	  was	  added	  and	  the	  solution	  was	  stirred	  for	  30	  more	  min.	  
The	  mixture	  was	  allowed	  to	  reach	  r.t.	  and	  then	  was	  extracted	  with	  Et2O	  (2x)	  after	  addition	  of	  water.	  
The	   organic	   layers	   were	   washed	   with	   brine	   and	   dried	   over	   MgSO4	   before	   concentration	   to	  
dryness.	  	  The	  crude	  was	  then	  purified	  by	  flash	  column	  chromatography	  eluting	  20%EtOAc	  in	  heptane.	  
The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  68	  (124mg,	  0.3mmol,	  86%)	  as	  
a	  white	  solid.	  
¹H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ	  7.31	  (br,	  1H),	  7.15	  (d,	  J=8.5	  Hz,	  2H),	  6.82	  (d,	  J=8.2	  Hz,	  2H),	  5.14	  (s,	  2H),	  
4.23	  (s,	  2H),	  3.75	  (s,	  3H),	  3.73	  (s,	  3H),	  2.80	  (s,	  3H),	  1.35	  (s,	  9H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  159.71,	  
S51	  
	  
155.74,	  129.58,	  129.37,	  127.46,	  122.28,	  114.32,	  80.15,	  79.54,	  75.61,	  56.16,	  55.30,	  42.22,	  34.12,	  28.44;	  
LC-­‐MS,	  6	  min	  run,	  (ESI+)	  m/z	  414.2038	  [M+H]+,	  Rt	  =	  4.4	  min.	  
	  
methyl	   (E)-­‐2-­‐(2-­‐(4-­‐methoxybenzyl)-­‐5-­‐methyl-­‐4,5-­‐dihydropyrrolo[3,4-­‐c]pyrazol-­‐6(2H)-­‐ylidene)acetate	  
(69)	  
	  
68	  (124mg,	  0.3mmol)	  was	  solubilized	  in	  DCM	  (2ml)	  and	  hydrogen	  chloride	  (4M	  in	  1,4-­‐dioxane,	  0.48ml,	  
0.12mmol)	  was	  added.	  The	  resulting	  mixture	  was	  stirred	  at	  rt	  for	  4h.	  Then,	  volatiles	  were	  removed	  
under	  reduced	  pressure	  and	  the	  solid	  crude	  was	  solubilized	  in	  dioxane	  (2ml).	  To	  this	  suspension,	  Et3N	  
(0.021ml,	  0.15mmol)	  was	  added	  and	  the	  final	  suspension	  was	  stirred	  at	  rt	  for	  1h.	  Afterwards,	  water	  
was	  added	  followed	  by	  DCM.	  The	  two	  resulting	  layers	  were	  separated	  and	  the	  aq.	  phase	  was	  extracted	  
further	  with	  DCM	  (2x).	  The	  organics	  were	  then	  combined,	  washed	  with	  brine	  and	  dried	  MgSO4	  before	  
concentration	  to	  dryness.	  The	  crude	  was	  then	  purified	  by	  flash	  column	  chromatography	  (MeOH/DCM	  
4:96).	  The	  desired	  fractions	  were	  concentrated	  to	  dryness	  in	  vacuo	  to	  afford	  69	  (37.4mg,	  0.12	  mmol,	  
40%)	  as	  a	  yellow	  solid.	  	  
¹H-­‐NMR	  (400	  MHz,	  CDCl3):	  δ	  7.28-­‐7.24	  (m,	  2H),	  7.06	  (s,	  1H),	  6.89	  (m,	  2H),	  5.44	  (s,	  2H),	  4.75	  (s,	  1H),	  4.26	  
(s,	  2H),	  3.80	  (s,	  3H),	  3.76	  (s,	  3H),	  3.03	  (s,	  3H);	  13C	  NMR	  (125	  MHz,	  CDCl3):	  δ	  169.59,	  169.22,	  159.63,	  
159.58,	   146.01,	   145.39,	   133.02,	   132.61,	   129.50,	   129.40,	   128.02,	   125.34,	   124.64,	   115.38,	   114.26,	  
107.76,	  106.69,	  55.93,	  55.90,	  55.31,	  53.44,	  51.22,	  45.91,	  42.92,	  38.70,	  21.87,	  21.30;	  LC-­‐MS,	  6	  min	  run,	  
(ESI+)	  m/z	  314.1487	  [M+H]+,	  Rt	  =	  3.5	  min.	  
	  
methyl	  2-­‐(5-­‐methyl-­‐2,4,5,6-­‐tetrahydropyrrolo[3,4-­‐c]pyrazol-­‐6-­‐yl)acetate	  (19)	  
	  
A	   0.05	  M	   solution	   of	  69	   (37.4mg,	   0.12mmol)	   in	   EtOH	   (2.4ml)	  was	   hydrogenated	   in	   an	  H-­‐cubePro.	  
Initially,	  the	  parameters	  (temperature:	  40°C,	  pressure:	  30bar	  and	  flowrate:	  0.5ml/min)	  were	  selected	  
and	   a	   10%	   Pd/C	   CatCart	   was	   fitted	   in	   the	   instrument.	   After	   pumping	   pure	   EtOH	   for	   10	  min,	   the	  
injection	  line	  was	  moved	  into	  the	  flask	  containing	  the	  starting	  material	  solution	  and	  the	  hydrogenation	  
process	  was	  started.	  The	  reaction	  was	  monitored	  by	  LC-­‐MS.	  Upon	  completion,	  solvent	  was	  evaporated	  
in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	   in	  TFA	  (0.35ml)	  and	  anisole	   (0.025ml,	  0.72mmol)	  was	  
subsequently	  added	  to	  the	  reaction	  flask.	  The	  final	  mixture	  was	  heated	  at	  80	  °C	  for	  12	  h.	  After	  cooling,	  
the	  volatiles	  were	  removed	  in	  vacuo	  and	  the	  solid	  residue	  was	  dissolved	  in	  MeOH/water/MeCN	  3:1:1.	  
The	  latter	  sample	  was	  filtered	  and	  injected	  in	  an	  AutoPurification	  HPLC/MS	  system	  and	  purified	  under	  
S52	  
	  
basic	  conditions.	  The	  desired	  fractions	  were	  evaporated	  to	  afford	  19	  (12mg,	  0.061mmol,	  51%)	  as	  a	  
reddish	  solid	  
¹H-­‐NMR	  (500	  MHz,	  MeOD):	  	  δ	  7.31	  (s,	  1H),	  4.10-­‐4.07	  (m,	  1H),	  4.05	  (dd,	  J=1.1,	  11.9	  Hz,	  1H),	  3.73	  (s,	  3H),	  
3.51	  (ddd,	  J=1.0,	  1.7,	  11.9	  Hz,	  1H),	  2.78	  (dd,	  J=6.1,	  16.0	  Hz,	  1H),	  2.71	  (dd,	  J=6.7,	  16.0	  Hz,	  1H),	  2.58	  (s,	  
3H);	  13C	  NMR	  (125	  MHz,	  MeOD4):	  δ	  173.45,	  122.95,	  121.00,	  61.85,	  53.94,	  52.34,	  41.50,	  39.12;	  HRMS	  


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































methyl	  2-­‐(5-­‐methyl-­‐2,4,5,6-­‐tetrahydropyrrolo[3,4-­‐c]pyrazol-­‐6-­‐yl)acetate	  (19)	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
